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Protein engineering was employed to study the role of active site residues 
of trichosanthin (TCS)，a RNA N-glycosidase which cleaves the N-
glycosidic bond of adenine-4324 of 28S rRNA. Based on the three-
dimensional structure of TCS, sequence homology of TCS to other related 
proteins and computer-aided molecular modeling, glutamine 156, 
glutamate-189 and glutamate-160 were surmised to play a role in the 
catalysis of the enzyme. These codons of TCS cDNA were mutated by 
polymerase chain reaction using mutagenic primers. The mutants were 
expressed in Escherichia coll and the mutated proteins were purified and 
their biological activities assayed. The results of the present study suggest 
the involvement of a carboxylate group in the active site for catalysis. 
Glutamate-160 in wild-type TCS serves to provide the carboxylate group. 
On the other hand, glutamate-189 can serve as a back-up of the 
carboxylate group in case the functional group of glutamate-160 is lost. 
Although glutamine-156 is highly conserved in plant ribosome-
inactivating proteins, it does not participate directly in catalysis. It is 
interesting to find that mutation of glutamine-156 to alanine would result 
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Chapter 1 Introduction 
Trichosanthin (TCS) is isolated from the root tuber of Trichosanthes 
kirilowii Maximowicz of the Cucurbitaceae family. Based on the 
structural similarities and functional properties, TCS belongs to the 
ribosome-inactivating proteins (RIPs). Like other RIPs from plant, 
TCS is an N-glycosidase which cleaves the N-C glycosidic bond of A-
4324 of 28S rRNA (Zhang and Liu, 1992). TCS is the active 
ingredient of the Chinese medicine Tian-hua-fen，the root tuber. In 
China, Tian-hua fen has been used to induce abortion for centuries. 
The discovery that TCS can inhibit the replication of type 1 human 
immuno-deficiency virus (HIV-1) in vitro (McGrath et al., 1989) has 
aroused considerable research interests. The cDNA (Shaw et al, 1991) 
and the genomic DNA (Chow et al., 1990) of TCS gene has been 
cloned. An efficient expression system has been developed for the 
overexpression of TCS in Escherichia coli (Zhu et al., 1992). 
Recently, three-dimensional structure of TCS has been solved by x-ray 
crystallography to 1.7A resolution (Dong, unpublished data). In the 
present study, protein engineering techniques were employed to study 
the structure-function relationships of TCS. The following 
introduction sections will briefly describe the properties of the protein 
as well as the strategy of the protein engineering of TCS. 
1_1_ Chemical and Physical Properties of Trichosanthin 
Similar to other RIPs, trichosanthin is a highly basic protein. Its pi 
value equals to 9.4, as determined by glycerol gradient isoelectric 
focus method (Jin et al., 1981; Wang, 1985). The cDNA of TCS codes 
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for a prepropeptide of 289 amino acids (Shaw et al., 1991). The first 
23 residues resemble a consensus secretory signal peptide and the last 
19 amino acids comprise a propeptide which presumably is cleaved in 
post-translational processing (Chow et al, 1991). It was reported that 
TCS with the 19 amino acid propeptide was found to be less active 
than the mature TCS (Zhu et al., 1992). The evidence supported the 
hypothesis that the propeptide sequence keeps the cytotoxic protein in 
an inactive form. The mature TCS consists of 247 amino acids (Chow 
et al., 1991; Shaw et al., 1990) which contains no cysteine residue, 
therefore no disulfide linkage can be formed. From its amino acid 
composition, it was calculated that the molecular weight of TCS is 
27140 dalton (Chow et al., 1991; Shaw et al., 1990). The pure 
crystalline TCS contains no carbohydrate and phosphate moiety (Jin et 
al., 1985; Wang, 1985)，despite the fact that many RIPs are 
glycoproteins. 
1.2. Activities of Trichosanthin at the cellular level 
TCS is an abortifacient protein. It is the active ingredient of the 
Chinese herb medicine, Tian-hua-fen. Tian-hua-fen has been used as a 
folk-medicine in China for a long time. As early as the 16th century, 
one of the famous Chinese scholars Li Shi-tseng described in his book 
"Compendium of Materia Medica" that Tian-hua-fen can "reestablish 
menstruation and facilitate expulsion of detained placenta". In China, 
TCS has been used to induce abortion via intra-amniotic or intra-
muscular injection. The drug was effective in inducing abortion, with 
only mild side effects and a successful rate of 94% (Liu et al” 1985). 
TCS has also been used to treat ectopic pregnancy and trophoblastic 
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tumours (Wang, 1985). The actions of TCS were attributed to its 
specific cytotoxicity to trophoblasts. (Anonymous, 1976). 
TCS also has effects on the immune system. It exhibited cytotoxicity to 
macrophages (Barbieri and Stirpe, 1982). In addition, it was shown to 
have immunosuppressive effects on a variety of cell-mediated and 
humoral immunity responses (Leung et al., 1986). 
TCS was shown to have anti-HIV activities (McGrath et al., 1989). It 
inhibits HIV-1 replication in both acutely infected T-lymphoblastoid 
cells and chronically infected macrophages in vitro. A formulated 
preparation of trichosanthin, GLQ223, has entered clinical trial phase 
n in treating Acquired Immunodeficiency Syndrome (AIDS) patients. 
Preliminary results suggested that TCS may have some anti-HIV 
activity in vivo as indicated by p24 antigen level and CD4+ cell count. 
However, there is also considerable side effects such as myalgia, fever, 
dementia, etc (Kahn et aL, 1990; Byers et aL, 1990). 
1.3. Activities of Trichosanthin at the molecular level 
The mechanism of action of TCS remained obscure until the discovery 
that TCS belongs to the family of ribosome-inactivating proteins. It 
has been shown that TCS is a potent inhibitor of protein synthesis in 
cell-free translation system (Yeung et al” 1988). The cytotoxic effect 
of TCS can be rationalized by its ability to inhibit protein synthesis. 
Presumably, the protein kills cells by arresting protein synthesis after 
entering the cytoplasm. It explains why trophoblasts and macrophages 
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are more susceptible to attack by TCS since they have high pinocytotic 
activity (Stirpe et al., 1992). 
Ribosome-inactivating proteins (RIPs) can be classified into two types. 
Type I RIPs are single-chain, basic proteins of molecular weight 26 -
30 kDa. They are potent inhibitors of protein synthesis in cell-free 
system. The order of magnitude of ID50 ranges from 1 nM to 1 pM 
(Stirpe et al” 1992). Type II RIPs are proteins consist of two different 
polypeptide chains connected by disulfide linkage. The A chain is 
homologous to type I RIP and is responsible for the toxicity of the 
molecule. The B chain is a galactose-specific lectin that binds to cell 
surfaces. The lectin domain of type II RIP facilitates the 
internalization of the toxin and hence the cytotoxicity of type 11 RIPs 
is much higher than type I RIPs. 
Among the REPs, ricin represents the most well-studied model. Ricin, 
a type n RIP, is isolated from caster bean plant {Ricinus communis). It 
was not known how RIPs inhibit protein synthesis until ricin A-chain 
was shown to have RNA N-glycosidase activity (Endo and Tsumgi， 
1988). The enzyme is highly specific which cleaves the N-glycosidic 
bond at adenine-4324 in 28S rRNA of rat liver ribosomes (Fig. 1.1). 
Ademne-4324 locates on an exposed loop with a stem near the 3' end 
of the 28S rRNA. The loop is highly conserved throughout the 
evolution. There is evidence suggesting that the loop is involved in 
binding of elongation factors (EF) (Osborn and Hartley, 1990; 
Brigotti et al； 1989; Gessner and Irvin, 1980; Moazed et al., 1988). It 
was shown that the removal of A-4324 by ricin interferes with EF-1-
4 
NHg 
Ricin ~ ~ • 
CD O 
(3 > 
� C - G ^ 
G - C 
G - A 
C - G 
^ C - G 
A - U 
4319 A - U 4350 
Fig. 1.1 N-glycosidase activity of ricin. Ricin cleaves the N-
glycosidic bond of A-4324 of 28S rRNA and releases the adenine. 
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and GTP-dependent aminoacyl-tRNA binding to ribosomes as well as 
EF-2-catalyzed GTP hydrolysis and translocation (Furutani et al., 
1992), and hence arrest protein synthesis. 
Ricin A-chain is extremely toxic. A single molecule of the toxin, once 
present in the cytoplasm, is sufficient to kill a cell (Endo et al” 
1991).The Km and kcat values of ricin A-chain, which are 2.6 uM and 
1777 min-1 respectively, demonstrate how toxic the ricin A-chain is 
since the concentration of ribosomes is of the order of 1 uM (Endo 
and Tsurugi, 1988). 
TCS belongs to type I RIPs. It is highly homologous to ricin A-chain. 
The primary sequences of the two proteins share a high degree of 
homology (Zhang and Wang, 1986). Not only resemble in their amino 
acid sequences, the two molecules can also superimpose each other 
(Fig. 1.2). The homology of the two proteins have led researchers to 
speculate that TCS also have N-glycosidase activities. 
The educated guess was indeed correct. It was shown that TCS is able 
to cleave the N-glycosidic bond of adenine-4324 of 28S rRNA (Zhang 
and Liu, 1992). The cleavage is highly specific. It was estimated that 
one adenine molecule was released per ribosome (Zhang and Liu, 
1992), despite the fact that there is approximate 7000 N-glycosidic 
bonds in one eukaryotic ribosome. 
Like ricin A-chain, TCS is an efficient enzyme and hence very toxic. 
The Km and kcat values of TCS are 1.7 uM and 926 min-1 
6 
• ^^H 
Fig. 1.2 Superimposition of TCS and ricin. Yellow and red lines 
represents a-backbone of TCS and ricin A-chain respectively. 
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respectively (Shaw P. C.，Department of Biochemistry, The Chinese 
University of Hong Kong, unpublished data). These values are 
comparable to that of ricin. The kinetic data explain the toxicity of 
TCS to ribosome. Only a trace amount of TCS, of the order of 1 nM, 
is enough to abolish all the protein synthesis in a cell-free translation 
system (Zhu etal, 1992). 
While the ribosome-inactivating activities of TCS can be attributed to 
its N-glycosidase activities, the mechanism of its anti-HIV activities is 
still elusive. It was reported that TCS inhibits the replication of HIV-1 
at a concentration which do not affect cell protein synthesis (McGrath 
et al., 1989). This suggests that TCS affects the HIV-infected cells 
through a mechanism other than its abilities to inhibit protein 
synthesis. It was reported that TCS also has nuclease-like activities (Li 
et al., 1991). At high concentration of TCS (higher than 500 nM), 
supercoil DNA is nicked to open circular form and finally to linear 
form. The role of the nuclease-like activities of TCS is still unknown. 
It seems a long road for us to understand the mechanism of its anti-
HIV activities. 
1.4. Objective and Strategy of Protein engineering of 
Trichosanthin 
While many biological activities of TCS have been characterized, their 
molecular basis is not fully understood. Enzymatic cleavage of 
adenine-4324 of 28S rRNA explains some of the action of TCS. 
However, the mechanism of the N-glycosidase reaction is still unclear. 
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In the present study, protein engineering was employed to investigate 
the role of several active site residues of TCS. Site-directed 
mutagenesis was performed to mutate the TCS cDNA. The mutated 
proteins were purified and their biological activities assayed. Together 
with the help of crystallographic structure of TCS, sequence homology 
and computer-aided molecular modeling, it was aimed to uncover the 
enzymatic mechanism of TCS. 
In order to study the enzymatic mechanism, we have to first locate the 
active site of TCS. Fig. 1.3 shows the a-carbon backbone of TCS. A 
prominent cleft was observed, as indicated by an arrow. The cleft is 
large enough to accommodate a rRNA substrate and is surmised to be 
the putative active site of TCS. 
There are several highly conserved residues lying within the active site 
cleft. Fig. 1.4 shows the sequence homology of ribosome-inactivating 
proteins. There is a total number of nine invariant residues. Six of 
them lie within the active site cleft: they are tyrosine-70 and 80， 
glutamate-160, alanine-161，arginine-163 and tryptophan-192. 
Conservation of these amino acid residues suggests that they contribute 
to indispensable roles in the normal functioning of TCS. 
Among these invariant residues, the role of glutamate-160 received 
much research focuses. Site-directed mutagenesis of other ribosome-
inactivating proteins suggested that glutamate-160 might also be 
important in the catalysis of TCS. The first report concerning the role 
of this conserved amino acid residue came from the study of Shiga-
9 
論德 
Fig. 1.3 a-carbon backbone of TCS. Arrow indicates active site 
cleft of TCS 
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1 1立 2立 3(1 4立 TCS DVSFRLS GATSSS忍GVFISNLSKALPNERKL YDIPLL RSSLPGSQRYALI 
a - m m c DVSFRLS gadprs^gmfikdlSnalpfrekv ynipll lpsvsgagryllm 
L u f f i n A D V R F S L S GSSSTS忍SKFIGDLSEALPSNGTVYNLTILL SSASGASRYTLM 
R i c i n A 工FPKQYPIINFTTA GATVQS*STNFIRAVaGRLTTGADVRHEIPVLPNRVGLPINQRFILV 
A b r i n A E D R P I K F S T E GATSQS"S"KQFIEALaERLRGGL I HDIPVLPDPTTLQERNRYITV 
MAP A P T L E T I A S L D LNNPT fflLSFITNlSTKVADKTEQ C T I Q K I SKTF TQRYSYI S06 VTSITLD LVNPTAGQ^ SSFVDKISNNVKDPNLK YGGTDI AVIGPPSKEKFLR 
B P S I AAKMAKNVDKPLFTATFNVQASSAD*S"ATFIAGiaNKLRNPAHFSHNEPVLE>PVEPNVPPSRWFHV 
S L T A l KEFTLDFS TAKT"SVDSL«NV 工觅 SAIGTPLQTISSGGTSLLMIDSGSGDNLiFAV 
S L T A 2 K E F T I D F S T Q Q S " S V S S L N S I S T E I S T P L E H I S Q G T T S V S V I N H T H G S YFAV 
60 IQ, 80 9立 10立 
T C S HLTNYADET I S V A I D VTNVS'IMGYRAGDT SYFFNEASATE AAKYVF KDAM 
a - m i n c HLFNYDGKT ITVAVD VTNV^IMGYLADTT SYFFNEPAAEL ASQYVF RDAR 
L u f f i n A TLSNYDGKA ITVAVD VSQL'S'IMGYLVNST SYFFNESDAKL ASQYVF KGST 
R i c i n A ELSNHAELS VTLALD VTNA'SWGYRAGNS AYFFHPDNQEDAEAITHLF TDVQ 
A b r i n A E L S N S D T E S 工EVGID VTNA'SWAYRAGTQ SYFLRDAPSS ASDYLF TGTD 
MAP D L I V S S T Q K I T L A I D MADL'SVLGYSDIANNKGR AFFFKDVTEAV ANNF FPGATG 
S O 6 I N F Q S S R G T VSLGLK RDNL'SVVAYLAMDNTNVNRAYYF R S E I T S A E S T A L F P E A T T 
B P S I V L K A S P T S A G L T L A I R ADNI'S'LEGFKSSDG TWWELT PGLI 
S L T A l dvrgidpeegrfnnlrlivernnl'SVtgfvnrtnnvfyrfadf SHVTFPGTT 
S L T A 2 DIRGLDVYQARFDHLRLIIEQNNL"SVAGFVNTATNTFYRFSDF THISVPGVT 
i m 1 2 立 1 3 立 14 (1 1 5 立 
T C S RKVTLPYSGN^ERLQTAAGKIRENIPLGLPA&DSAITTLFYY NANSA ASA LMV 
a - m m c RKITLPYSGN^ERLQIAAGKPREKIPIGLPASaDSAISTLLHY DSTAA AGA LLV 
L u f f i n A I VTLPYSGN"2*EKLQTAAGKIREKIPLGFPA2!]DSALTTIFHY DSTAA AAA FLV 
R i c i n A NRYTFAFGGN^DRLEQLAGNLRENIELGNGPaEEAISALYYY STGGTQLPT LARS F I I 
A b r i n A QH SLPFYGT'S'GDLERWAHQSRQQIPLGLQASiTHGIS F F SGGNDNEE KART L I V 
MAP TNRIKLTFTGS'S'GDLEKNGG LRKDNPLGIF碰ENSIVNIYGK AGDVKKQ ALF FLL 
S 0 6 ANQKALEYTED"5"QSIEKNAQITQGDQSRKELG2QGIDLLSTSMEAVNKKARVVKD EARF L L I 
BPS工 PGATYVGFGGT忍RDLLGDTDKL TNVALGRQQSDEDAVTALHGRTKADKASGPKQQQAREAVTT 
S L T A l A VTLSGDSS忍TTLQRVAGISRTGMQINRHSSa TTSYLDLMSHSGTSLTQSVAR AMLR 
S L T A 2 T VSMTTDSS忍TTLQRVAALERSGMQISRHSai VSSYLALMEFSGNIMTRDASR AVLR 
1 5 6 16 立 170 18 立 1 8 1 20 立 
T C S L I Q S T S幽A S Y K F 工EQQIGKRVDKT F L P S L A I I S L E N S 彻SALSKQIQIASTNNGQF 
a - m m c L I Q T T A S ^ A B i F K Y lEQQIQERAYRD EVPSLA T I S L E N S 朋SGLSKQIQLAQGNNGIF 
L u f f i n A I L Q T T A啦 S S F K Y l E G Q I I E R I S K N QVPSLA TISLENSL朋SALSKQIQLAQTNNGTF 
R i c i n A C I Q M I S幽A S F Q Y IEGEMRTRIRYN RRSAPDPS V I T L E N S 彻GRLSTAIQE SNQGAF 
A b r i n A 工工QMVA腿ASFRY I S N R V R V S I Q T G TAFQPDAA MISLENN 動NLRG VQE SVQDTF 
MAP A I Q M V S a秘 a F K Y I S D K I P S E K Y E E VTVDEY MTALENN 彻AKLSTAVYNSKPS TTT 
S 0 6 AIQMTA卿A取FRY IQNLVIKNFPNK FNSENK V I Q F E V N 歡K I S T A I Y G DAKNGVF 
B P S I LLLMVNSS^TaFQTVSGFVAGLLHPKAVEKKSGKIGNEMKAQVNG朋QDLSAALLKTDVKPPPG 
S L T A l F V T V T A啦L S F R QIQRGFRTTLDDLSGRSYVMTAEDVDLTLN 彻GRLSSVLPD YHGQDS 
S L T A 2 F V T V T A S a L a . F R QIQREFRQALSE TAPVYTMTPGDVDLTLN 前GRLDAALGE YRGEDG 
21Q, 2211 23立 2411 
T C S E S P W L I N A Q N Q R V T I T N V D A G W T S N I A L L L N R N N M A a-mmc rtpivlvdnkgnrvqitnvtskwtsniqllntrniaegdngdvstthgfssy 
L u f f i n A KTPWITDDKGQRVEITNVTSKWTKNIQLLLNYKQNVA 
R i c i n A ASPIQLQRRNGSKFSVYDVS I L I P I I A L M V Y R C A P P P S S Q F 
A b r i n A PNQVTLTNIRNEPVIVDSLSH PTVAVLALMLFVCNPPN 巡 p ATKCQL ATS P V T I S PWIFKTVEE 工 KLVMGLLKS S 
q 0 6 NKDYDFGFGKVRQVKDLQMGLLMY LGKPKSSNEAN SPOT KSPAKFTEKM GVRTAEQAAATLGILLFVEVPGGLTVAKALELFHASGGKPI 
V R V G R I S F GSINAILGSVALILNCHHHASRVARMA SDEFRSMCPADGRVRGITHNKILW 
S L T A 2 V R V G R I S F NNISAILGTVAVILNCHHQGARSVRAV NEESQPECQITGDRPVIKINNTLW 
S L T A l DSSTLGAILiMRRTISS 
S L T A 2 ESNTAAAFLNRKSQFLYTTGK 
Fig 1 4 Sequence homology of ribosome-inhibiting proteins. 
The'reference for the amino acid sequences: TCS, trichosanthin (Shaw et al 1991); a-mmc alpha 
iox^f I S L a £ Shiga^ike toxin II (Robertus, 1992). Invariant residues are outlined. In the present 
study, Q156, E160 and E189 of TCS are studied. 
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like toxin I of Escherichia coli (Hovde et al., 1988). Glutamate-167, 
which corresponds to glutamate-160 of TCS, was mutated to aspartate. 
The activity of the mutated protein was decreased by 1000 folds, as 
measured by cell-free translation. The role of glutamate-167 was 
concluded to be crucial since mutation of glutamate to aspartate only 
shorten the side chain of the amino acid by one -CH2- group and such 
a small modification results in large decrease in activities. 
Mutagenesis of Shiga-like toxin II from Escherichia coli also gave 
similar results. Glutamate-167, which corresponds to glutamate-160 of 
TCS, of Shiga-like toxin II was mutated to aspartate. The mutated 
protein was found to be at least 100 folds, as measured by cell-free 
translation system, less active than the wild-type protein (Jackson et al, 
1990). 
The role of glutamate-177, which corresponds to glutamate-160 of 
TCS, of ricin A-chain was investigated. Glutamate-177 was mutated to 
aspartate. The ribosome-inactivating activity of the aspartate-177 
mutant was decreased 80 folds (Schlossman et al” 1989). From the 
above evidence, it is reasonable to surmise that glutamate-160 of TCS 
may play an important role in catalysis. 
The story of searching the role of glutamate-177 of ricin A-chain had 
not concluded yet. The glutamate-177 was also mutated to alanine. The 
alanine-177 mutant was found to have higher activity, which is 1/20 of 
the wild-type activity, than the aspartate-177 mutant (Schlossman et 
al., 1989). The finding queried the role of the carboxylate group of 
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glutamate-177 in the catalysis of ricin A-chain. It was postulated that 
the loss of carboxylate group at position 177 was partially 
compensated by the carboxylate group of glutamate-208, which locates 
nearby. Two lines of evidence support the postulation. The first 
evidence came from double mutation of ricin A-chain. Glutamate-208 
of wild-type ricin A-chain and of alanine-177 mutant was mutated to 
aspartate. The activity of the double mutant, E177AE208D, was totally 
abolished while the single mutant, E208D, remained fully active 
(Frankel et al., 1990). This implied that relative higher activity of 
alanine-177 mutant requires the present of glutamate-208. The second 
evidence came from the structure of alanine-177 mutant which was 
recently solved by x-ray crystallography (Kim et al.，1992). The 
results showed that the carboxylate group of glutamate-208 rotates 
into the vicinity of alanine-177, substituting the role of glutamate-177. 
Since TCS is homologous to other ribosome-inactivating proteins, 
experiences in site-directed mutagenesis of Shiga-like toxins and ricin 
are highly valuable in locating the active site residues of TCS. In the 
present study, the focus was mainly on the role of glutamate-160. Role 
of glutamate-189, which corresponds to glutamate-208 of ricin A_ 
chain, was also investigated. Another conserved amino acid residues, 
glutamine-156, was also studied. It was observed in the three-
dimensional structure of TCS that glutamine-156 forms a hydrogen 
bond to glutamate-189. The hydrogen bond was thought to anchor the 
glutamate-189 in position. In order to study the roles of and the inter-
relationships between these three residues, nine mutants were 
constructed, including single and double mutants: E160D, E160A, 
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E189D，E189A，E160AE189D，E160AE189A, Q156A, Q156AE160A 
and Q156AE189A. 
A deletion mutant, AS159EAAR, of TCS was constructed. There is 
contradictory evidence concerning the role of glutamate-177 of ricin 
A-chain. The gene coding for S176EAAR, which corresponds to the 
S159EAAR of TCS, was deleted from the ricin A-chain cDNA. The 
mutated transcript was found to inhibit protein synthesis in a cell-free 
translation (May et al., 1989). The researcher argued that mutated 
transcript translates a protein, despite missing the SEAAR 
pentapeptide, which retains inhibitory effect to ribosome. This may 
suggest that the conserved pentapeptide SEAAR, which includes the 
glutamate-177, is not important in the function of the toxin. Our work 
of constructing the deletion mutant was to clarify the role of the 
pentapeptide SEAAR in TCS. 
The ultimate goal of protein engineering of trichosanthin is to 
understand its mechanism of action and then we can apply our 
knowledge to create a better drug. There is several potential 
application of TCS. In the first place, crystalline TCS has already been 
applied in China for abortion. Moreover, TCS is now being tested for 
its ability to treat AIDS and as an immunotoxin to act against tumor. 
At present, side effect of TCS remains an obstacle towards an effective 
drug against AIDS. A better understanding of its structure-function 
relationship may contribute to engineering a drug with higher efficacy 
and smaller side effect. 
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Chapter 2 
Materials and Methods 
Chapter 2 Materials and Methods 
2.1. General Techniques 
2.1.1 _ Ethanol Precipitation of DNA and RNA 
0.1 volume of 3.0M sodium acetate (pH 5.2) and 2 volumes (for DNA) 
or 2.5 volumes (for RNA) of cold 100% ethanol were added to a DNA 
solution. The DNA was precipitated at -70°C for 30 minutes. The 
precipitate was pelleted at 12,000g for 20 minutes at 4°C in a 
microfuge. The pellet was washed with 70% ethanol. After 
centrifugation at 12,000g for 10 minutes at 4°C，the pellet was dried in 
a SpeedVac (Savant Instruments Inc.) and dissolved in H2O, TE (pH 
8.0) (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) or a suitable buffer at the 
desired concentration. 
2.1.2. Spectrophotometric quantification of DNA and 
RNA 
Spectrophotometer (Hitachi 100-10 UV-VIS) was used routinely for 
quantification of nucleic acid. An OD280 of 1 corresponds to 50 ug/ml 
for double-stranded DNA, 40 ug/ml for single-stranded DNA and RNA, 
and 20 ug/ml for single-stranded oligonucleotides. 
2.1.3. Minipreparation of Plasmid DNA 
This method was adopted from Maniatis et al (1989) with minor 
modifications. A single bacterial colony was inoculated into 2 ml of LB 
medium containing the appropriate antibiotic in a capped test-tube. The 
culture was incubated overnight at 3 7 � C with vigorous shaking. 
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Bacterial pellet of 1.5 ml culture was collected by centrifugation at 
12,000g for 5 minutes in a microfuge. The pellet was resuspended in 
100 ul PI (Section 2.8.2) containing 100 ug/ml RNase. After 100 ul P2 
(Section 2.8.2) was added, the mixture was allowed to stand on ice for 5 
minutes. Then 100 ul P3 (Section 2.8.2) was added followed by 
standing on ice for 15-30 minutes. Cell debris and chromosomal DNA 
were removed by centrifugation at 12,000g for 15 minutes in a 
microfuge. The supernatant was transferred to a fresh microfuge tube 
and was re-centrifuged if white precipitate was present. The plasmid 
DNA was recovered by ethanol precipitation and was dissolved in 15 ul 
H20. 
2.1.4. Preparation of Plasmid DNA using Qiagen-pack 
100 Cartridge 
This method was modified from the 3rd Edition of the Qiagen 
Application Protocol. A single bacterial colony was inoculated into 400 
ml of LB medium containing the appropriate antibiotic. The culture was 
incubated overnight at 37°C with vigorous shaking. Bacterial pellet of 
the culture was collected by centrifugation at 5,000 ipm for 5 minutes at 
4°C (Hitachi High Speed Centrifuge SCR20B with RPR 12-2 rotor). 
The pellet was resuspended in 10 ml PI containing 100 ug/ml RNase. 
After 10mlP2 was added, the mixture was allowed to stand on ice for 5 
minutes. Then 10 ml P3 was added followed by standing on ice for 15-
30 minutes. Cell debris and chromosomal DNA were removed by 
centrifugation at 13,000 rpm for 15 minutes at 4 � C (RPR 20-2 rotor). 
The supernatant was transferred to a fresh tube and was re-centrifuged 
for 30 minutes at 4°C to obtain a supernatant of about 30 ml. 
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A QIAGEN-pack 100 column (QIAGEN Inc.) was equilibrated with 3 
ml of QBT (750 mM NaCl, 50 mM MOPS, 15% ethanol, pH 7.0, 
0.15% Triton X-100). The flow was maintained by gravity. 1/3 volume 
(about 10 ml) of the supernatant from the previous steps was applied to 
the column. The column was then washed with 10 ml QC (1.0 M NaCl, 
50 mM MOPS, 15% ethanol, pH 7.0). The plasmid DNA adsorbed onto 
the column was eluted by passing through 5 ml of QF (1.25 M NaCl, 50 
mM MOPS, 15% ethanol, pH 8.2). The above procedure was repeated 
two more times to purify the plasmid DNA in the remaining 
supernatant. 
The plasmid DNA was pooled together and was recovered by 
isopropanol precipitation. 0.7 volume of isopropanol was added to the 
eluted DNA. After incubated on ice for 15 minutes, the DNA was 
recovered by centrifugation at 13,000 rpm (RPR 18-3 rotor) for 20 
minutes at 4°C. The pellet was washed with 70% ethanol and 
lyophilized (Section 2.1.1). The DNA was dissolved in 200 ul of water 
or TE (pH 8.0) (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) and stored at 
2.1.5. Preparation of Plasmid DNA using Magic™ 
Minipreps DNA Purification kit from Promega 
The following procedure is based on the method recommended by the 
supplier. A single bacterial colony was inoculated into 5 ml of LB 
medium containing the appropriate antibiotic in a capped test-tube. The 
culture was incubated overnight at 3 7 � C with vigorous shaking. 
Bacterial pellet was collected by centrifugation at 12,000g for 5 minutes 
in a microfuge. The pellet was resuspended in 200 ul PI containing 100 
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ug/ml RNase. After 200 ul P2 was added, the mixture was allowed to 
stand on ice for 5 minutes. Then 200 ul P3 was added followed by 
standing on ice for 15-30 minutes. Cell debris and chromosomal DNA 
were removed by centrifugation at 12,000g for 15 minutes in a 
microfuge. The supernatant was transferred to fresh microfuge tube and 
was re-centrifuged if white precipitate was present. 1 ml Magic™ 
Minipreps DNA Purification Resin was added to the supernatant. A 
Magic™ Minipreps Column was attached to a 3 ml syringe barrel. The 
slurry was then pushed gently into the column. The column was washed 
with 2 ml Column Wash Solution. The column was centrifuged for 30 
seconds in a microfuge to remove the last trace of solution. 50 ul of 
water preheated to 65-70°C was applied to the column. A fresh 
microfuge tube was attached to the outlet of the column. Solution 
containing the plasmid DNA was recovered by centrifugation at 
12,000g for 30 seconds in a microfuge. 
2.1.6. Preparation and Transformation of Escherichia coli 
Competent Cell 
The following method was adopted from Maniatis et al (1989) with 
minor modification. Escherichia coli strain DH5a was streaked directly 
from a frozen stock onto the surface of an LB agar plate. The plate was 
incubated overnight at 37°C. Single colony from the plate was 
transferred to 5 ml SOB. The culture was incubated overnight at 37°C. 
The 5 ml culture was inoculated into 50 ml SOB. The cells were grown 
at 37°C until OD^oo reached 0.8. The cells were harvested by 
centrifugation at 5,000 rpm for 10 minutes at 4 � C (Hitachi High Speed 
Centrifuge SCR20B with RPR 20-2 rotor). After standing the tubes in 
an inverted position for 1 minute to remove the last traces of medium, 
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the pellet was resuspended in 20 ml of ice-cold FSB (10 mM Potassium 
acetate (pH 7.5), 45 mM MnCl2, 10 mM CaCl2, 100 mM KCl, 3 mM 
Hexamminecobalt chloride, 10%(v/v) Glycerol, pH 6.4). The 
suspension was kept on ice for 10 minutes. The cells were recovered by 
centrifugation at 5,000 rpm for 10 minutes at 4°C (Hitachi High Speed 
Centrifuge SCR20B with RPR 20-2 rotor). After standing the tubes in 
an inverted position for 1 minute to remove the last traces of medium, 
the pellet was resuspended in 4 ml of ice-cold FSB. 140 ul of DMSO 
was added and the suspension was kept on ice for 15 minutes. Then an 
additional 140 ul of DMSO was added. The competent-cell suspension 
was dispensed into aliquots of 200 ul each. The aliquots was snap-
freezed in liquid nitrogen and stored at -70°C until needed. 
Just before use, the competent cells were thaw in hand. Transforming 
DNA (less than 10 ul) was added to competent cells and mixed well. 
The tubes were stored on ice for 30 minutes and then heat-shocked at 
4 2 � C for exactly 90 seconds. The tubes were rapidly transferred to an 
ice bath to chill the cells for 2 minutes. Then 800 ul of SOC or LB 
medium (Section 2.8.3) was added. The cultures were incubated at 
3 7 � C for 45 minutes to allow the bacteria to recover and to express the 
antibiotic resistance marker encoded by the plasmid. 100 to 200 ul of 
the transformed culture was spreaded onto a LB agar plate containing 
an appropriate antibiotic. After the liquid had been absorbed，the plates 
were inverted and incubated at 37°C overnight. 
2.1.7. Agarose Gel Electrophoresis of DNA 
The agarose gels were prepared with 0.5-2.0% (w/v) agarose (Sigma A-
9539) dissolved in Ix TAE or Ix TBE buffer containing 0.5 ug/ml of 
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ethidium bromide. The volume of DNA samples were adjusted to 5-60 
ul with water. 6x gel-loading buffer (Section 2.8.1) was added to the 
DNA sample to a final concentration of Ix. After loading the samples 
into the wells, electrophoresis was performed at constant voltage of 50-
100 V in a gel tank containing Ix TAE or Ix TBE. When 
electrophoresis was finished, DNA was visualized on a Spectroline 
Model TC-302 UV transilluminator (302nm) and, if necessary, 
photographed with a Polaroid MP-4 instant camera and Polaroid 667 
instant film through a HOYA R(25A) red filter. 
2.1.8. Purification of DNA from Agarose Gel using 
GeneClean® (BIO 101 Inc.) kit 
The following procedure worked best with TAE gel. The agarose gel 
stained with ethidium bromide was observed under ultra-violet 
illumination. The band containing the desired DNA was cut out from 
the gel using a razor blade. The weight of the gel slice was determined 
and 3 volumes of 6M Nal solution was added. After melting the gel at 
5 5 � C for 5 minutes, 5-15 ul Glassmilk® silica matrix was added. The 
mixture was kept on ice for 15 minutes with occasional shaking. The 
suspension was centrifuged in a microfuge at 13,000 rpm for 1 minute. 
The pellet was washed with 0.7 ml NEW WASH solution. The 
suspension was then centrifuged in a microfuge at 13,000 rpm for 1 
minute. The washing procedure was repeated for two more times. The 
washed pellet was resuspended with 10-20 ul of water or TE (pH 8.0) 
(10 mM Tris-Cl, 1 mM EDTA, pH 8.0) buffer. After incubation at 55�C 
for 5 minutes, supernatant containing the DNA was recovered by 
centrifugation in a microfuge at 13,000 rpm for 1 minute. 
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2.1.9. Polymerase Chain Reaction (PCR) 
Site-directed mutagenesis was carried out by PCR using mutagenic 
primer. Oligonucleotide primers were designed in such a way that the 
mismatches were located at the center of the primer with not less than 8 
matches on both sides. A restriction site was included or created 
(without affecting the coding frame) at the 5’ end of the primer to 
facilitate subsequent subcloning. Primers used in the present study are 
listed in Fig. 2.1. 
The following method was based on Maniatis et al (1989) with 
modification. Plasmids harbouring the TCS gene, pET 58210 or 
pTrc58210, were used as templates for the polymerization. Vent™ 
DNA polymerase and lOx amplification buffer were supplied by the 
New England Biolabs. 
5 ul of lOx amplification buffer, 8 ul of dNTP mix (1.25 mM of dATP, 
dCTP, dGTP，dTTP), 5 ul of forward primer (20 uM) and 5 ul of 
reverse primer (20 uM) were mixed together in a 500 ul microfuge tube. 
Template (up to 2 ug) was added to the reaction mixture. Water was 
added so that final volume of the mixture was 50 ul. The mixture was 
incubated at 94°C 5 minutes to denature the template DNA. While the 
tube was still at 94°C, 2 units of Vent™ DNA polymerase was added. 
The tube was vortexed briefly and was centrifuged to spin down liquid 
that may attach on the surface of the tube. 50 ul of light mineral oil 
(Sigma M5904，Molecular Biology Grade) was overlaid onto the 
reaction mixture to prevent evaporation of the solution during 
incubation. 
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1. Oligo E160D (37 mer): mutation of TCS glutamate 160 to aspartate 
CATTCAGTCGACGTCT GAG GCTGCGAGGTATAAATTT 
Asp 
2. Oligo E160A (37 mer): mutation of TCS glutamate 160 to alanine 
CATTCAGTCGACGTCT GOT GCTGCGAGGTATAAATTT 
Ala 




4. Oligo E189A (61 mer): mutation of TCS glutamate 189 to alanine 
and create a unique site Hae II on TCS gene 
TTATTAGTACTCGCTATCTGAATTTGCTTGGAGAG aacQCt CCAAC 
TATT GGC CAAACTTA Hae II 
Ala 
5. Oligo E189D (32 mer): mutation of TCS Glutamate 189 to Aspartate 
GAGAGAGCGCTCCAACTATT GTC CAAACTTAT 
Asp 
6. Oligo Q156A (25 mer): Mutate TCS Glutamine 156 to Alanine 
-AGACGTCGA CGC AATGAGTACCAT 
Ala 
7. Reverse primer of pTrc58210 (36 mer) 
AAGCTTGCATGCCTGCACCTCGACTCTAGAGGATCC 
8. Forward primer of pET 58210 (20 mer) 
AACGGTTTCCCTCTAGAAAT 
9. Primer E (20 mer) 
CAAACTGCTGCAGGCAAAAT 
Fig. 2.1 Primers used in polymerase chain reaction. 
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The amplification was carried out under the following cycles: 
Cycle Denaturation Annealing Polymerization 
1st Cycle 5 minutes at 94�C 2 minutes at 50�C 3 minutes at 72�C 
2nd to 34th Cycle 1 minutes at 94�C 2 minutes at 50�C 3 minutes at 72�C 
35th Cycle 1 minutes at 94�C 2 minutes at 50°C 10 minutes at 72�C 
After amplification, the mineral oil was removed. 10 ul of 6x agarose 
gel loading buffer was added and the sample was loaded to an agarose 
gel. After electrophoresis, the PCR product was recovered by 
GeneClean® kit (Section 2.1.8). 
2-1.10- Restriction Digestion of DNA 
Restriction digestion of DNA was carried out in a volume of 10 to 80 ul 
in the appropriate buffers as suggested by the suppliers. The reaction 
mixture was incubated at 37°C for 3 hours or overnight. After digestion, 
the reaction mixture was analyzed by agarose gel electrophoresis. 
2.1.11 • Ligation of DNA fragments 
The following procedure described the general conditions for ligation of 
DNA. DNA fragments to be ligated were mixed together. The mixture 
was incubated at 4 5 � C for 5 minutes. If the reaction was a blunt end 
ligation, 50% (w/v) PEG 6000 was added to a final concentration of 5% 
to enhance ligation efficiency. Then lOx ligation buffer, provided by the 
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supplier, was added to the reaction mixture to a final concentration of 
Ix. 3-6 units of T4 DNA ligase (New English Biolabs.) was added and 
the reaction mixture was incubated overnight at room temperature (for 
blunt end ligation) or at 16�C (for stick end ligation). 
2.1.12. Autoradiography 
Kodak X-OMAT AR diagnostic film was used for DNA sequencing 
film. Films were exposed in a Kodak X-Omatic cassette at -70°C for 
one overnight to one week. Films were developed with Kodak X-ray 
developer for 5 minutes, fixed with Kodak X-ray fixer for 5 minutes 
and rinsed with tap water for 5 minutes. 
2.1.13. SDS-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
All SDS-Polyacrylamide gels were run with the Mini-PROTEAN II 
electrophoresis cell (BioRad Laboratories, Inc.) The cell was assembled 
according to the manufacturer's instructions. 
Running gel (12%) was prepared as follows: 
H2O 1.6 ml 
1.5M Tris-Cl (pH 8.8) 1.3 ml 
30% Acrylamide 2.0 ml 
10% (w/v) SDS 50 ul 
10% (w/v) ammonium persulfate 50 ul 
TEMED 2 ul 
3.5 ml of the running gel solution was poured into the gap between the 
glass plates. 1 ml isopropanol was added to keep the solution out of 
atmospheric oxygen and to remove air bubbles on solution surface. The 
polymerization should be completed in 15 minutes. 
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Stacking gel (3%) was prepared as follows: 
H2O 1.4 ml 
30% Acrylamide 0.33 ml 
1.0 M Tris-Cl (pH 6.8) 0.25 ml 
10% (w/v) SDS 20 ul 
10% (w/v) ammonium persulfate 20 ul 
TEMED 2 ul 
After the running gel was set, the isopropanol layer was removed. 2 ml 
of stacking gel solution was poured and the comb was inserted to the 
gap between the glass plates. 
The volumes of protein samples were adjusted to 15 ul with water and 
15 ul of 2x SDS gel loading buffer was added. The samples were boiled 
for 5 minutes and then applied to the wells. The gel was run at 30 mA 
until the bromophenol blue reached the bottom of the running gel (about 
45 minutes). The gel was removed from the electrophoresis cell and 
then can be stained with Coommassie Brilliant Blue or used to establish 
a western blot. 
2.1.14. Staining of Protein in polyacrylamide gel 
After electrophoresis, the gel was immersed in 100 ml staining solution 
(0.15% (w/v) Coommassie Brilliant Blue R-250, 31.25% (v/v) ethanol, 
10% (v/v) acetic acid) for 30 minutes at 70�C. The gel was then 
destained by soaking it in destaining solution (25% (v/v) ethanol, 8% 
(v/v) acetic acid) at 7 0 � C for 4-8 hours. The destaining solution was 
changed several times until the destaining was completed. 
2.1.15. Western Blot detection of TCS 
After electrophoresis, the stacking gel was discarded. The size of the 
running gel was measured. Six 3MM filter paper and one nitrocellulose 
25 
filter of the same size as the running gel was cut out. The nitrocellulose 
filter was boiled for 3 minutes in distilled water. The 3MM filter paper 
was wetted with transfer buffer. The semi-dry electroblotter (ANCOS) 
was set up as follows: 
-ve 
nitrocellulose filter 
OAyfAyf -ptlfpf* r^ or^ pt* ^^^ ^^ 
— ^ ^ p o l y a c v l a m i d e gel 
+ve 
Constant current of 0.8 mA per cm2 of nitrocellulose filter was applied 
for 1 hour. 
The method for color development was based on the enzyme-linked 
immunodetection of anti-TCS antibody using anti-IgG second 
antibodies conjugated with alkaline phosphatase. ProtoBlot® 
Immunoscreening system (Promega) was used for immunodetection of 
TCS. The following procedure was modified from the method 
recommended by the supplier. After electroblotting, the nitrocellulose 
filter was immersed into 10 ml TBSTM for 30 minutes. TBSTM was 
then discarded and 10 ml anti-TCS antibody solution (1:500 in TBSTM 
with 0.03% NaN3) was added and the filter was incubated with swirling 
at room temperature for 2 hours or at 4 � C for overnight. The filter was 
then washed with 20 ml TEST for 5 minutes. The washing was repeated 
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two more times. 10 ml anti-rabbit IgG antibody conjugated with 
alkaline phosphatase(l:7500 in Ix TBSTM with 0.03% NaNs) was 
added and the filter was incubated with swirling at room temperature 
for 2 hours. The filter was then washed with 20 ml TEST for 5 minutes. 
The washing was repeated two more times. The filter was blotted dry 
with paper towels. Color development solution was prepared as follows: 
AP buffer (appendix) 10 ml 
NET (supplied with the kit) 66 ul 
BCIP (supplied with the kit) 33 ul 
The washed nitrocellulose filter was immersed in freshly prepared color 
development solution. The solution was swirled until color developed. 
When the color had developed to the desired intensity, the reaction was 
stopped by rinsing the filter in distilled water for several minutes, 
changing the water several times. The filter was then air-dried for long 
term storage. 
2.1 _16. Liquid Scintillation Counting 
A Beckman LS 1801 liquid scintillation counter was used for 35s 
countings. The scintillation fluid used was prepared by mixing 660 ml 
of toluene, 330 ml of Triton X-100, 5g of PPO and 0.25 g of POPOP. 
Filters were placed in plastic scintillation vials containing 4 ml of 
scintillation fluid. 
2.1.17. Minimization of Ribonuclease (RNase) activity in 
experiments involving RNA 
Contamination of RNase is a major problem in experiments involving 
RNA. The following precautions were done to minimize the RNase 
activity. Labware and chemicals were set aside for RNA experiments 
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only. Glassware was treated by baking at 180�C oven for 8 hours or 
more to inactivate any RNase contamination. All reagents was prepared 
using RNase-free glassware, autoclaved water, and chemicals reserved 
for work with RNA. Diethyl pyrocarbonate (DEPC), a strong inhibitor 
of RNase, was added to the reagents to final concentration of 0.1% 
(v/v). The solution was incubated at 37�C for at least 12 hours and 
autoclaved for 15 minutes at 15 Ib/sq. in. on liquid cycle. Before use, 
electrophoresis tanks were treated with 3% H2O2 for 10 minutes, then 
rinsed thoroughly with water that had been treated with 0.1% DEPC. 
2.2. Site-Directed Mutagenesis of Trichosanthin 
2.2.1. Construction of E160D, E160A and SEAAR deletion 
mutants 
PCR mutagenesis and subcloning (Fig. 2.2) 
Oligo E160D, El 60A and SEAAR were used as the forward primer in 
PCR mutagenesis to create E160D, El60A and SEAAR deletion 
mutants respectively. Reverse primer of pTrc58210 was used as the 
backward primer. 1 ug of pTrc58210 was used as the DNA template. 
PCR was performed as described (Section 2.1.9). The 0.28 kb PCR 
fragment was separated from primers and template by agarose gel 
electrophoresis (Section 2.1.7) and was purified from the gel using 
GeneClean® kit (Section 2.1.8). Finally，the recovered DNA was 
dissolved in 15 ul H2O. All the DNA was digested with restriction 
enzyme BamH I and Sal L After agarose gel electrophoresis, the cut 
fragments were purified using GeneClean® kit. The DNA was 
dissolved i n l S u l H2O. 
28 
Nco I 1 ^ ^ 0 . 4 7 kb 
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0.28kb of PCR fragment and 
4.6kb fragment of pET8c were 
ligated together. 
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Fig 2.2 Construction of AS159EAAR deletion mutant, E160D 
and El 60A mutants 
t _ --
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5 ug of pTrc58210 was digested with restriction enzymes Nco I and Sal 
/• After agarose gel electrophoresis, the 0.47 kb fragment was purified 
using GeneClean® kit and was finally dissolved in 15 ul H2O. 
5 ug of pET 58210 was digested with restriction enzymes Nco I and 
BamH L After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
1 ul of 4.6 kb fragment of pET 8c, 1 ul of 0.47 kb fragment of 
pTrc58210, 2 ul of water were mixed together. The mixture was 
incubated at 45°C for 3 minutes. 0.5 ul of lOx T4 DNA ligase buffer 
and 0.5 ul of T4 DNA ligase (New England Biolabs, 400 New England 
Biolabs units per ul) was added and the mixture was incubated at 16°C 
for 4 hours. Then 4 ul of 0.28 kb PGR fragment was added to the 
reaction mixture. An additional 0.5 ul of lOx DNA ligase buffer and 0.5 
ul of T4 DNA ligase were added and the mixture was incubated at 16°C 
overnight. 
The ligation mixture was added to 200 ul of DH5a competent cell. 
Transformation was performed as described in Section 2.1.6. 
Screening of Transformed Colonies 
Plasmid was isolated from transformed colonies by mini-preparation 
(Section 2.1.3). The size of the plasmid was analyzed by agarose gel 
electrophoresis with the pET 58210 as a marker. The plasmid was also 
analyzed by restriction digestion with Nco I and BamH I. The mutation 
was finally confirmed by DNA sequencing (Section 2.3) 
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2-2.2. Construction of E189A mutant and E160A E189A 
double mutant 
Construction of pACYC 58210 (Fig. 2.3) 
5 ug of pET 58210 and 1 ug of pACYC 177 were digested with 
restriction enzymes BamH 13nd Pst L After agarose gel electrophoresis, 
the 0.4 kb fragment from pET 58210 and the 3.0 kb fragment from 
pACYC 177 were purified using GeneClean® kit and were finally 
dissolved in 15 ul H2O. 3 ul of 0.4 kb fragment, 1 ul of 3.0 kb 
fragment, 4.5 ul of water, 1 ul lOx T4 DNA ligation buffer and 0.5 ul of 
T4 DNA ligase (New England Biolabs, 400 New England Biolabs 
units/ul) was mixed together and incubated at 16°C. The ligation 
mixture was transformed into DH5a as described in Section 2.1.6. The 
transformed colonies were screened by minipreparation and restriction 
digestion. The ligated pACYC 58210 was then prepared by Qiagen-
pack 100 cartridge (Section 2.1.4). 
PGR mutagenesis and subcloning (Fig. 2.4) 
Primer E and oligo El 89A were used as the forward and backward 
primer. 1 ug of pET 58210 and 1 ug of pET El 60A were used as the 
DNA template to create E189A and E160A E189A mutants 
respectively. PGR was performed as described (Section 2.1.9). The 0.26 
kb PGR fragments were separated from primers and template by 
agarose gel electrophoresis (Section 2.1.7) and were purified from the 
gel using GeneClean® kit (Section 2.1.8). Finally, the recovered DNA 
was dissolved in 15 ul H2O. All the DNA was digested with restriction 
enzyme Pst I and Sea L After agarose gel electrophoresis, the cut 
31 
PstI ^ I p “ e
n 旧 f ^-^^^BamHI 
BamH I // X pET 58210 \ / Digested with Pst I and BamH I 
3.0 kb fragment of 
pACYC 177 was ligated 
to 0.4 kb fragment of 
pET 58210 1 r 
PstI 
^ ^ Sea I 
, ^^ BamH-I - -
pACYC 58210 
\ 3.4 kb I 
Fig. 2.3 Construction of pACYC 58210 
32 
Ps“ PstI 
0 l l ^ I ^^ urnm^^ mmm kimHI pET 58210 , PGR PstI t Seal I ::丨丄 
0.26 kb PGR W 
fragment � \ El89A mutation 
\ z Digested with Sea I and Pst I. 
0.26 kb of PGR fragment was ligated 
^ to 3.1kb fragment of pACYC 58210. PstI Sail / E189Amutation 
广 0.28 k^\jBamH I Ncol BamHI . / \ 
©I pACYC E^189A | Ncoi / / y^BamHI 
\ Digested with BamH I // pET 58210 
\ and Sal I. or | 
\ / PETE160A i 
Digested with Nco I / ^ \ 5.4 kb ^ 
and BamHh / Digested wi th / /co / \ J 
- … - \ / > 紐 
[ 0.47 kb fragment of pET 58210 or 
y pET El 60A, 0.28 kb fragment of 
pACYC El89A and 4.6 kb fragment 
Nco I of pET 8c were ligated together. 
^ ^ E189A mutation 
// pETE189A ] 
or 
\\ pETE160AE189A // 
J / Fig 2.4 Construction of El 89A and 
E160AE189A mutants. 
. •. - • •---
33 
fragments were purified using GeneClean® kit. The DNA was 
dissolved in 15 ul H2O. 
0.5 ug of pACYC 58210 was digested with restriction enzymes Pst I 
and Sea I. After agarose gel electrophoresis, the 3.1 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
1 ul of 3.1 kb fragment of pACYC 58210, 6 ul of 0.26 kb of PGR 
fragment, 1 ul of 50% PEG, 1 ul of lOx T4 DNA ligase buffer were 
mixed together. 1 ul of T4 DNA ligase (New England Biolabs, 400 
New England Biolabs units per ul) was added and the mixture was 
incubated at room temperature overnight. The ligation mixture was 
added to 200 ul of DH5a competent cell and transformation was 
performed as described in Section 2.1.6. 
Screening of transformed colonies 
Plasmid was isolated from transformed colonies by Magic™ Minipreps 
(Section 2.1.5). The size of the plasmid was analyzed by agarose gel 
electrophoresis with the pACYC 58210 as a marker. The plasmid was 
also analyzed by restriction digestion with Hae 11. The mutation was 
finally confirmed by DNA sequencing (Section 2.3) 
After confirmation of sequences, plasmid containing the mutation was 
large-scale prepared by Qiagen-pack 100 (Section 2.1.4). The plasmids 
containing mutated TCS gene were named pACYC E189A and pACYC 
E160AE189A for E189A and E160AE189A mutants. 
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Subdoning of mutated TCS gene into expression vector 
5 ug of pET 58210 was digested with restriction enzymes Nco I and Sal 
/• After agarose gel electrophoresis, the 0.47 kb fragment was purified 
using GeneClean® kit and was finally dissolved in 15 ul H2O. 
0.5 ug of pET 8c was digested with restriction enzymes Nco I and 
BamH I. After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
2 ug of pACYC E189A and pACYC E160A E189A was digested with 
restriction enzymes BamH I and Sal L After agarose gel electrophoresis, 
the 0.28 kb fragment was purified using GeneClean® kit and was 
finally dissolved in 15 ul H2O. 
1 ul of 4.6 kb fragment of pET 8c, 3 ul of 0.47 kb fragment of pET 
58210 were mixed together. The mixture was incubated at 45°C for 3 
minutes. 0.5 ul of lOx T4 DNA ligase buffer and 0.5 ul of T4 DNA 
ligase (New England Biolabs, 400 New England Biolabs units per ul) 
was added and the mixture was incubated at 16�C for 4 hours. Then 4 ul 
of 0.28 kb PCR fragment was added to the reaction mixture. Additional 
0.5 ul of lOx DNA ligase buffer and 0.5 ul of T4 DNA ligase were 
added and the mixture was incubated at 16�C overnight. The ligation 
mixture was transformed into DH5a competent cells as described in 
Section 2.1.6. The mutation was then confirmed by DNA sequencing. 
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2-2.3. Construction of E189D mutant and E160A E189D 
double mutant 
PGR mutagenesis and subcloning (Fig. 2.5) 
pET forward primer and oligo E189D were used as the forward and 
backward primer. 1 ug of pET 58210 and pET El 60A was used as the 
DNA template to create E189D and E160A E189D mutants. PGR was 
performed as described (Section 2.1.9). The 0.58 kb PGR fragments 
were separated from primers and template by agarose gel 
electrophoresis (Section 2.1.7) and were purified from the gel using 
GeneClean® kit (Section 2.1.8). Finally, the recovered DNA was 
dissolved in 15 ul H2O. All the DNA was digested with restriction 
enzyme Hae II and Nco /. After agarose gel electrophoresis, the cut 
fragments were purified using GeneClean® kit. The DNA was 
dissolved in 15 ul H2O. 
10 ug of pET El60A E189A was digested with restriction enzymes Nco 
I and BamH I. After agarose gel electrophoresis, the 0.75 kb fragment 
was purified using GeneClean® kit and was finally dissolved in 15 ul 
H2O. All of the recovered 0.75 kb fragment was digested with 
restriction enzyme Hae II. After agarose gel electrophoresis, the 0.17 kb 
fragment was purified using GeneClean® kit and was finally dissolved 
in 15 ul H2O. 
0.5 ug of pET 8c was digested with restriction enzymes Nco I and 
BamH 1. After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
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2 ul of 4.6 kb fragment of pET 8c, 6.5 ul of 0.17 kb PCR fragment was 
mixed. The mixture was incubated at 45�C for 3 minutes. 1 ul of lOx T4 
DNA ligase and 0.5 ul of T4 DNA ligase (New England Biolabs, 400 
New England Biolabs units per ul) was added and the mixture was 
incubated at 16�C for 4 hours. Then 4 ul of 0.58 kb of pET 
E160AE189A was added to the reaction mixture. An additional 0.5 ul 
of lOx DNA ligase buffer and 0.5 ul of T4 DNA ligase were added and 
the mixture was incubated at 16°C overnight. The ligation mixture was 
added to 200 ul of DH5a competent cell and transformation was 
performed as described in Section 2.1.6. 
Screening of transformed colonies 
Plasmid was isolated from transformed colonies by mini-preparation 
and Magic™ Minipreps (Section 2.1.3 and 2.1.5). The size of the 
plasmid was analyzed by agarose gel electrophoresis with the pET 
58210 as a marker. The plasmid was also analyzed by restriction 
digestion with Hae 11. The mutation was finally confirmed by DNA 
sequencing (Section 2.3) 
2.2-4. Construction of Q156A mutant 
PCR mutagenesis and subcloning (Fig. 2.6) 
pET forward primer and oligo Q156A were used as the forward primer 
and backward primer. 1 ug of pET 58210 was used as the DNA 
template to create Q156A mutant. PCR was performed as described 
(Section 2.1.9). The 0.47 kb PCR fragments were separated from 
primers and template by agarose gel electrophoresis (Section 2.1.7) and 
were purified from the gel using GeneClean® kit (Section 2.1.8). 
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Finally，the recovered DNA was dissolved in 15 ul H2O. 13.5 ul of the 
DNA was digested with restriction enzyme Nco I and Sal I. After 
agarose gel electrophoresis, the cut fragments were purified using 
GeneClean® kit. The DNA was dissolved in 15 ul H2O. 
7.5 ug of pET 58210 was digested with restriction enzymes BamH I and 
Sal L After agarose gel electrophoresis, the 0.28 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
0.5 ug of pET 8c was digested with restriction enzymes Nco I and 
BamH L After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
7.5 ul of 0.47 kb PGR fragment, 4 ul of 0.28 kb fragment of pET 58210, 
1.5 ul of lOx T4 DNA ligase buffer, 1 ul of 10 mM ATP and 1 ul of T4 
DNA ligase (New England Biolabs, 400 New England Biolabs units per 
ul) was mixed and the mixture was incubated at 16°C for 4 hours. Then 
1 ul of 4.6 kb of pET 8c，0.3 ul of lOx DNA ligase buffer, 0.5 ul of T4 
DNA ligase, 0.5 ul of 10 mM ATP and 0.7 ul of water were added and 
the mixture was incubated at 16°C overnight. The ligation mixture was 
added to 200 ul of DH5a competent cell and transformation was 
performed as described in Section 2.1.6. 
Screening of Transformed Colonies 
Plasmid was isolated from transformed colonies by mini-preparation 
and Magic™ Minipreps (Section 2.1.3 and 2.1.5). The size of the 
plasmid was analyzed by agarose gel electrophoresis with the pET 
58210 as a marker. The plasmid was also analyzed by restriction 
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digestion with Nco I and BamH L The mutation was finally confirmed 
by DNA sequencing (Section 2.3). 
2-2.5. Construction of Q156A E160A mutant (Fig. 2.7) 
5 ug of pET Q156A was digested with restriction enzymes BamH land 
Sal I. After agarose gel electrophoresis, the 0.28 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
7.5 ug of pET E160A was digested with restriction enzymes BamH I 
and Sal L After agarose gel electrophoresis, the 0.28 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
0.5 ug of pET 8c was digested with restriction enzymes Nco I and 
BamH I. After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
5 ul of 0.47 kb fragment of pET Q156A，6 ul of 0.28 kb fragment of 
pET E160A, 1.5 ul of water, 1.5 ul of lOx T4 DNA ligase buffer and 1 
ul of T4 DNA ligase (New England Biolabs, 400 New England Biolabs 
units per ul) was mixed and the mixture was incubated at 16°C for 4 
hours. Then 1 ul of 4.6 kb of pET 8c, 0.3 ul of lOx DNA ligase buffer, 
0.5 ul of T4 DNA ligase and 1.2 ul of water were added and the mixture 
was incubated at 16°C overnight. The ligation mixture was added to 
200 ul of DH5a competent cell and transformation was performed as 
described in Section 2.1.6. 
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Screening of transformed colonies 
Plasmid was isolated from transformed colonies by mini-preparation 
and Magic™ Minipreps (Section 2.1.3 and 2.1.5). The size of the 
plasmid was analyzed by agarose gel electrophoresis with the pET 
58210 as a marker. The plasmid was also analyzed by restriction 
digestion with Nco I and BamH L The mutation was finally confirmed 
by DNA sequencing (Section 2.3). 
2,2.6. Construction of Q156A E189A mutant (Fig. 2.8) 
5 ug of pET Q156A was digested with restriction enzymes BamH I and 
Sal I. After agarose gel electrophoresis, the 0.28 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
7.5 ug of pET E189A was digested with restriction enzymes BamH I 
and Sal L After agarose gel electrophoresis, the 0.28 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
0.5 ug of pET 8c was digested with restriction enzymes Nco I and 
BamH I. After agarose gel electrophoresis, the 4.6 kb fragment was 
purified using GeneClean® kit and was finally dissolved in 15 ul H2O. 
5 ul of 0.47 kb of pET Q156A fragment, 6 ul of 0.28 kb fragment of 
pET El 89A, 1.5 ul of water, 1.5 ul of lOx T4 DNA ligase buffer and 1 
ul of T4 DNA ligase (New England Biolabs，400 New England Biolabs 
units per ul) was mixed and the mixture was incubated at 16�C for 4 
hours. Then 1 ul of 4.6 kb of pET 8c，0.3 ul of lOx DNA ligase buffer, 
0.5 ul of T4 DNA ligase and 1.2 ul of water were added and the mixture 
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200 ul of DH5a competent cell and transformation was performed as 
described in Section 2.1.6. 
Screening of Transformed Colonies 
Plasmid was isolated from transformed colonies by mini-preparation 
and Magic™ Minipreps (Section 2.1.3 and 2.1.5). The size of the 
plasmid was analyzed by agarose gel electrophoresis with the pET 
58210 as a marker. The plasmid was also analyzed by restriction 
digestion with Nco I and BamH L The mutation was finally confirmed 
by DNA sequencing (Section 2.3). 
2.3. DNA sequencing 
The subcloned mutated TCS genes were verified by DNA sequencing. 
Sanger's method of DNA sequencing was employed in this purpose. 
Double stranded plasmids were used as template. 
2-3-1. DNA Sequencing Reaction 
T7Sequencing kit (Pharmacia) were used to carry out the reaction. The 
following method was based on the manual provided by the supplier. 8 
ul of water containing 1-2 ug of plasmid DNA was added to 2 ul of 2 M 
NaOH. The mixture was kept at room temperature for 10 minutes to 
allow denaturation of the template. Then 3 ul of 3 M sodium acetate 
(pH 4.5), 7 ul of water was added to neutralize the solution. The DNA 
was precipitated by adding 60 ul of chilled absolute ethanol. The 
solution was placed at -70�C for 30 minutes. The DNA was recovered 
by centrifugation at 13,000 rpm for 20 minutes at 4 � C in a microfage. 
The pellet was washed with 70% ethanol and lyophilized. The dried 
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pellet was then dissolved in 10 ul of water. 2 ul each of annealing buffer 
and 5 ng/ml primer solution was added to the template solution. The 
mixture was incubated at 37°C for 20 minutes and the at room 
temperature for 10 minutes. 3 ul of labeling mix, 1 ul of [a-35s]dATP 
or [a-35s]dCTP (10 mCi/ml, >1000 Ci/mmol, Amersham SJ304) and 
2 ul of diluted T7 DNA polymerase (1.5 units/ul, diluted with enzyme 
diluting buffer) were added to the reaction mixture. The mixture was 
incubated at room temperature for 5 minutes. During incubation, 2.5 ul 
of A-, G-, C-, and T-Mix Short was added to four labeled fresh 
microfuge tubes and were prewarmed at TTC. After incubation, 4.5 ul 
of the reaction mixture was added to each of the four prewarmed 
sequencing mixes. The four tubes were incubated at ST'^ C for 5 minutes. 
Then 5 ul of Stop solution was added to each tube. The sample was then 
kept at -20°C until use. 
2.3.2. DNA Sequencing Electrophoresis 
Preparation of 6% polyacrylamide gel 
42 g of urea (Molecular Biology Reagent, Sigma), 14.5 ml of 40% 
acrylamide stock solution (38%(w/v) acrylamide, 2%(w/v) N，N’-
methylene-bisacrylamide) and 10 ml of 1 Ox TBE buffer (Appendix) 
were added to 30 ml of water. Solution of urea was assisted by warming 
gently on a hot plate. After all the urea had been dissolved, water was 
added to make up the final volume to 100 ml. The acrylamide solution 
was then filtered through a Minipore 0.22 [im filter • The solution was 
degassed using vacuum pump. Just before pouring the gel, 0.8 ml of 
10% of freshly prepared ammonium persulfate and 80 ul of TEMED 
(BioRad Laboratories) were added to the monomer solution. 
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Treatment of the glass plate surface for gel casting 
The surface of a pair of glass plates (20 x 40 cm) were cleaned with 
distilled water and ethanol thoroughly. The entire surfaces of the plates 
which contact the gel were wiped with repel-silane 
(dimethyldichlorosilane solution 2%(w/v) in 1,1,1 -tricholoroethane) 
using lint-free tissue paper. Finally, the surfaces were wiped with 
ethanol again. 
Gel casting 
A pair of 0.4 mm thick spacers was placed between the treated glass 
plates. The margins and the bottom of the plate sandwich were sealed 
with tape. Then it was laid in a tray so that the plates inclined at an 
angle of about 20"". Immediate after adding the catalysts, the gel was 
poured into the gap between the plates. Great care was taken to avoid 
trapping of air bubbles inside the gel. The plate sandwich was placed 
horizontally and a sample comb was inserted into the gap between the 
plates. The gel was allowed to set for 30 minutes. 
Electrophoresis 
When the polymerization was complete, the comb was removed and the 
wells were washed thoroughly with water to remove any trace of 
unpolymeiized monomer. The gel plate sandwich was then assembled 
onto the gel tank. The upper and the lower buffer reservoirs were filled 
with Ix TBE buffer. The gel was pre-run at 1500 V for 30 minutes. 
Before loading, the sample was heated at 80°C for 2 minutes. 3 ul of 
sample was loaded into the well using a sequencing pipette 
(Drummond). The gel was then run at constant voltage of 1500 V. 
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Cooling and even heating was facilitated by placing a metal plate onto 
the sandwich. Running time was dependent on the distance between the 
sequence of interest and the primer annealing site. Usually, 
electrophoresis last for two to six hours. After the electrophoresis was 
complete, the glass plates were dissembled under the fixing solution 
(10%(v/v) acetic acid). The gel was fixed for 10 minutes. Then the gel 
was blotted onto a sheet of 3MM Whatman filter paper. A piece of 
plastic wrap was used to cover the gel surface. The gel was dried in a 
gel dryer (BioRad Laboratories, Model 543). Autoradiography was 
done to detect the sequencing bands. 
2.3.3. Resolving GC band compression 
If band compression occurred, Deaza TTSequencing Mixes (Pharmacia) 
were used instead of the standard Mix-Short provided in the 
T7Sequencing kit (Pharmacia). Moreover, the electrophoresis was run at 
higher temperature such as 65°C. 
2.4. Overexpression of mutated TCS in Escherichia coli 
Expression vectors containing mutated TCS genes were transformed 
into Escherichia coli expression host, BL21 (DE3，pLysS). Preparation 
of competent cells and transformation was performed as described in 
Section 2.1.6. 
A single colony of BL21 (DE3, pLysS) containing the mutated gene 
was inoculated in 5 ml M9ZB (Section 2.8.3) with 50 ug/ml Ampicillin 
and 25 ug/ml Chromophenicol. The culture was grown at 37°C 
overnight with vigorous shaking and then transferred to 500 ml M9ZB 
with the same amount of antibiotics. The culture was grown at 3TC 
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with vigorous shaking until OD600 = 0.8 (about 4 to 5 hours). The 
expression was then induced by adding isopropylthio-p-galactoside 
(IPTG) to a final concentration of 0.4 mM. The culture was grown at 
37°C for 3 more hours. The cell was collected by centrifugation at 
5,000 rpm (Hitachi High Speed Centrifuge SCR20B with RPR 12-2 
rotor) for 10 minutes at 4°C. After the supernatant was discarded, the 
weight of the wet cells was measured by subtracting the weight of the 
centrifuge tube. The pellet was resuspended in 15 ml of 50 mM 
NaH2P04 (pH 6.5) with 0.1 mM phenylmethysulfonyl fluoride (PMSF) 
and 0.1% (v/v) P-mercaptoethanol. The suspension was sonicated for 
six cycles (30 seconds sonication and 30 seconds cooling at 4°C) and 
was then centrifuged at 21,000g for 30 minutes at 4°C. The supernatant 
was collected and dialysed against 50 mM NaH2P04, pH 6.5. 
2.5. Purification of mutated TCS 
After dialysis, the supernatant prepared from Section 4 was applied to a 
CM Sepharose CL-6B column (1.6 x 26 cm) equilibrated with buffer A 
(50 mM NaH2P04, pH 6.5). The flow rate was kept at 15 ml/hr. The 
column was washed with buffer A until OD280 of the eluant was less 
than 0.05. TCS was eluted by applying buffer B (0.5 M NaCl in buffer 
A). The eluant was collected by fraction collector (3 ml per fraction). 
OD280 of the fraction was measured. Fractions with OD280 greater 
than 0.1 were collected and pooled together and dialysed against 10 
mM NaH2P04, pH 6.5. The eluant was concentrated to 15 - 20 ml by 
ultrafiltration and was loaded to a Mono-S HR 5/5 FPLC column. The 
flow rate was 1 ml/minute. The column was washed with colunm buffer 
(10 mM NaH2P04, pH 6.5) for 5 minutes. A 0 _ 0.1 M NaCl or 0 - 1 M 
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NaCl gradient (25 ml) was applied to elute the TCS. The peaks were 
collected and analysed by SDS-PAGE. The peak containing TCS was 
then dialysed against water. After dialysis, the purified protein was 
snap-freezed in liquid nitrogen and then lyophilized. 
2-6. Ribosome inactivating activity Assay using Rabbit 
Reticulocyte Lysate In Vitro Translation system 
Untreated rabbit reticulocyte lysate (Promega, L4153) was used to carry 
out in vitro translation. The method employed was modified from 
Yeung et al (1988). Master mix and working lysate were prepared as 
follows: 
Master Mix 
Creatine phosphate (0.8 M) 4 ul 
KCl/MgCl2 ( 2 M / 1 0 m M ) 10 ul 
H2O 16 ul 
Working Lysate 
Rabbit reticulocyte lysate (Promega) 100 ul 
H2O 100 ul 
Creatine kinase (5 mg/ml) 2 ul 
Hemine (1 mg/ml) 10 ul 
4 ul of master mix, 2 ul of 35s-methionine (Amershan SJ235, 15 
mCi/ml) was mixed with 4 ul of sample protein (TCS mutated protein 
in 0.5 mg/ml bovine serum albumin). 30 ul of working lysate was then 
added to initiate translation. The mixture was incubated at 30°C for 
exactly 30 minutes. 5 ul of the reaction mixture were diluted into 1 ml 
of water in a 15 ml test tube. 0.5 ml of 1 M NaOH / 10% H2O2 was 
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then added. The tube was incubated at 37°C for 45 minutes. 1 ml ice-
cold 25% trichloroacetic acid (TCA) was added to precipitate the 
translated protein and the tube was kept at 4°C for 30 minutes. The 
precipitate was collected by filtration through a GF/B filter under 
suction. The filter was washed three times with 5 ml of 8% TCA. 
Finally，the filter was washed with 1 ml of acetone. After the acetone 
had been evaporated, the filter was transferred to a vial containing 3 ml 
of scintillation fluid. Radioactivity was measured by liquid scintillation 
counting as described in Section 2.1.16. 
2.7. N-glycosidase activity Assay 
This method was adopted from May et al. (1989) with a modification 
that untreated rabbit reticulocyte lysate was used instead of treated one. 
2.7.1. Inactivation of ribosome in rabbit reticulocyte 
lysate 
Untreated rabbit reticulocyte lysate (Promega, L4153) was used as a 
source of ribosome. Master mix and working lysate were prepared as 
described in Section 6. 20 ul of master mix and 150 ul of working lysate 
was mixed. 30 ul sample protein (final concentration of 0.18 to 1 uM) 
was then added to initiate inactivation of ribosome. The mixture was 
incubated at 30°C for exactly 30 minutes. 
2.7.2. RNA extraction 
0.3 ml of water and 25 ul of 10% SDS was added to the reaction 
mixture. Protein was then removed by phenolxhloroform extraction. 
0.5 ml of phenol:chlorofonn:isoamyl alcohol (25:24:1) was then added 
and the mixture was vortexed vigorously for 1 minute. The protein 
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interface was pelleted by centrifugation at 13,000 rpm in a microfuge 
for 1 minute. The upper aqueous phase was collected and extracted with 
phenolichloroform two more times. The solution was extracted one 
more time with 0.5 ml of chlorofom:isoamyl alcohol (24:1). The RNA 
was recovered by ethanol precipitation. 50 ul of 3M sodium acetate, pH 
5.2 and 1 ml of ice-cold absolute ethanol were added to the upper 
aqueous phase of the last extraction. The mixture was kept at -70�C 
overnight. The RNA was precipitated by centrifugation at 13,000 rpm 
for 20 minutes in microfuge. The pellet was washed with 70% ethanol 
and then lyophilized. The RNA pellet was dissolved in 15 ul of water. 
2.7.3. Aniline Degradation 
Aniline was double-distilled and can be stored in dark for at least two 
weeks. 60 ul of freshly prepared aniline / acetic acid (IM / 2.8M) was 
added to 6 ul of RNA prepared from Section 7.2. The mixture was 
incubated at for 3 minutes. 7 ul of 3M sodium acetate, pH 5.2 and 
200 ul of absolute ethanol was added and the mixture was kept at -70°C 
for one hour. The RNA was precipitated by centrifugation at 13,000 
rpm for 20 minutes in a microfuge. The pellet was washed with 70% 
ethanol and then lyophilized. 
2-7.4. Electrophoresis of RNA in Agarose Gel containing 
Formamide 
The pellet from Section 7.3 was dissolved in 15 ul of 60% formamide in 
O.lx E buffer (3.6 mM Tris, 3 mM NaH2P04, 0.2 mM EDTA). The 
solution was incubated at 65°C for 10 minutes to melt any secondary 
structure of RNA. 2 ul of formamide gel loading dye (50% glycerol, 1 
mM EDTA (pH 8.0), 0.25% bromophenol blue) was added. The sample 
52 
« 
was loaded to 1.2% agarose gel (3 mM NaH2P04, 0.2 mM EDTA, 50% 
formamide). The gel was run at 50V for 2 to 3 hours. (3 mM NaH2P04, 
0.2 mM EDTA, 50% formamide). 
The gel was then stained with 0.5 ug/ml ethidium bromide in 0.1 M 
ammonium acetate for 45 minutes. When the staining was finished, the 
gel was visualized on a Spectroline Model TC-302 UV transilluminator 
(302nm) and, if necessary, photographed with a Polaroid MP-4 instant 
camera and Polaroid 667 instant film through a HOYA R(25A) red 
filter. 
2.8. Reagents and buffers 
2.8.1. Nucleic Acid Electrophoresis Buffers 
TAE (Tris-acetate), Ix 
40 mM Tris-acetate 
1 mM EDTA 
TBE (Tris-borate), Ix 
90 mM Tris-borate 
2 mM EDTA 
6x agarose gel loading buffer 
0.25% bromophenol blue 
40% (w/v) sucrose in water 
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2-8.2. Reagents for preparation of plasmid DNA 
PI 
50 mM Tris-Cl (pH 7.5) 
10 mM EDTA 





2.55 M potassium acetate (pH 4.8) 
2-8-3. Media for bacterial culture 
LB (Luria-Bertani medium) 
10 g bacto-tryptone 
5 g bacto-yeast extract 
10 g NaCl 
The pH of the solution was adjusted to 7.0 with ION NaOH and the volume was 
made up to 1 liter with water. The medium was sterilized by autoclaving for 20 
minutes at 15 lb./sq.in. on liquid cycle. 
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SOB medium 
20 g bacto-tryptone 
5 g bacto-yeast extract 
0.5 g NaCl 
10 ml 250 mM KCl 
The pH of the solution was adjusted to 7.0 with ION NaOH and the volume was 
made up to 1 liter with water. The medium was sterilized by autoclaving for 20 
minutes at 15 lb./sq.in. on liquid cycle. 5 ml of sterile 2 M MgCl2 was added to 
the medium just before use. 
SOC medium 
SOC medium was prepared by adding 20 ml of sterile 1 M glucose to 1 liter SOB 
medium 
M9ZB medium 
1 g NH4CI 
3 g KH2PO4 
15.2 g Na2P04.12H20 
10 g Tryptone 
5 g NaCl 
The volume was made up to 1 liter with water. The medium was sterilized by 
autoclaving for 20 minutes at 15 lb./sq.in on liquid cycle. 20 ml of 20% glucose 
and 1 ml of IM MgS04 was added to the medium just before use 
Media containing agar 
Liquid media were prepared according to the recipes given above. Just before 
autoclaving, 15 g ofbacto-agar was added to 1 liter liquid medium. 
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2-8.4. Reagents for SDS-PAGE 
2x SDS gel-loading buffer 
1 ml l.OM Tris-Cl pH 6.8 
4 ml 10% SDS 
2 ml Glycerol 
0.02 g Bromophenol blue 
0.2 ml (i-mercaptoethanol 
Water was added to 10 ml 
Staining solution 
0.575 g Coommassie brilliant blue R-250 
125 ml Ethanol 
40 ml Acetic acid 
235 ml water 
Detaining solution 
0.5 liter Ethanol 
0.16 liter Acetic acid 
Water was added to 2 liters 
2.8.5. Reagents for western blot 
Transfer buffer 
48 mM Tris-Cl 
39 mM Glycine 
1.3 mM SDS 
20% (v/v) methanol 
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TEST 
1.21 Ig Tris base 
8.76g NaCl 
0.5 ml Tween-20 
Water was added to 1 liter and pH was adjusted to 8.0. 
TBSTM 
3 g milk powder was added to 100 ml TBST. Solution of milk powder was 
assisted by heating briefly in a microwave oven . 
First antibody solution (titer=1:500) 
30 ul of rabbit anti-TCS serum was added to 15 ml of TBSTM containing 0.03% 
NaN3. 
Second antibody solution (titer= 1:7500) 
2 ul of goat anti-rabbit IgG (Protoblot® Immimoscreening system from Promega) 
was added to 15 ml of TBSTM containing 0.03% NaNs. 
AP buffer 
100 mM Tris-Cl pH 9.5 
100 mM NaCl 
5 mM MgCl2 
Color development solution 
10 ml AP buffer 
66 ul Nitroblue tetrazolium stock solution (Protoblot® Immimoscreening system 
from Promega). 33 ul 5-bromo-4-chloro-3-indolylphosphate stock solution 
(Protoblot® Immimoscreening system from Promega). The solution was prepared 
just before use and was protected from strong light 
57 
2.8-6. Reagents for DNA sequencing 
40% acrylamide solution 
38 g Acrylamide 
2 g N,N'-methylene-bisacrylamide 
Water was added to 100 ml. The mixture was warmed at 37°C to dissolve the 
chemical. 5 g of amberlite ion exchange resin (Sigma) was added and the mixture 
was stirred at room temperature for 30 minutes for the adsorption of metal ions 
that may inhibit the polymerization of acrylamide. The resin was then removed 
by filtration through a 3MM filter paper. The acrylamide solution was stored at 
4°C in amber bottle. 
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Chapter 3 
Construction of TCS 
mutants 
Chapter 3 Construction of TCS mutants 
3.1. Introduction 
In order to study the structure-function relationship of TCS, site-
directed mutagenesis was done to modify the active site residues. 
According to the three dimensional structure of TCS, sequence 
homology to other RIPs, and computer-aided molecular modeling, 
three sites (Q156, El60 and E189) were mutated systematically to 
elucidate their role in the biological activities of TCS. A total number 
of ten mutants were constructed: E160D, E160A, E189D, E189A, 
E160AE189D, E160AE189A, Q156A, Q156AE160A, Q156AE189A 
and AS159EAAR. 
Polymerase chain reaction (PGR) using mutagenic primer was 
employed to carry out the mutagenesis. The PGR fragments containing 
the mutation were subcloned into expression vector pET 8c. Mutated 
plasmids were screened by their size, restriction digestion and DNA 
sequencing. Entire portion of DNA sequence synthesized by PCR was 
sequenced to ensure there is no second site mutation. 
3.2. Results 
3,2.1. Construction of E160D, E160A and ASEAAR 
PCR and subcloning 
The strategy of construction is shown in Fig. 2.2 and the methods are 




Fig. 3.1a Agarose analysis of PCR product. Lane 1: ASEAAR 
mutation. Lane 2: E160D mutation. Lane 3: El60A mtation. Lane 4: X 
Hind n i digested marker. 
i R S ^ S I 
Fig. 3.1b Isolation of 4.6 kb fragment of pET58210. Lane 1: 
pET58210 digested with Nco I and BamH I. Lane 2: X Hind HI digested 
marker. Lane 3: pET58210 uncut plasmid. HK^hi^h 
Fig. 3.1c Isolation of 0.47 kb fragment of pTrc58210. Lane 1 and 2: 
pTrc58210 digested with Sal I and BamH 1. Lane 3: pTrc58210 uncut 







Section 2.1.9. One tenth of the PCR product was loaded to a 1% 
agarose gel. After electrophoresis, DNA fragments of 0.28 kb were 
obtained as expected (Fig 3.1a). The 0.28 kb fragments were purified 
by GeneClean® kit (Section 2.1.8). After digestion with Sal I and 
BamU /，the 0.28 kb fragments were ligated to the 4.6 kb fragment of 
pET 58210 (Fig 3.1b，lane 1) and 0.47 kb fragments of pTrc 58210 
(Fig 3.1c, lane 1 and 2). Control ligation reactions without the 
addition of 0.28 kb PCR fragments were also set up. The ligated DNA 
was transformed into Escherichia coli strain DH5a. The results of 
transformation were summarized in the following table. 
No. of transformants 
Control E160D El 60 A SEAAR 
1/10 of cell plated 21 ND 89 ^28 
1/100 of cell plated | n D I 88 IND 145 
ND: Not done 
Minipreparat ion of plasmid from transformants 
Ligation of the 0.28 kb PCR fragment, 0.47 kb and 4.6 kb of pET 
58210 fragments should give a plasmid of similar size to pET 58210. 
The transformed plasmid were screened firstly by their size. 12 colonies 
of E160D mutation, 8 colonies of E160A mutation and 4 colonies of 
SEAAR mutation were picked and grown on another LB ampicillin agar 
plate. Their plasmids were isolated by minipreparation 
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Fig. 3.2 Screening of transformed colonies. Lane 1-6, 9-14: E160D 
mutation, colony number 1 to 12. Lane 15-18: ASEAAR mutation, 
colony number 1 to 4. Lane 19-22, 25-28: El60A mutation, colony 
number 1 to 8. 
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(Section 2.1.3). The size of the plasmids were analyzed by 0.8% 
agarose gel electrophoresis (Fig 3.2). By comparing the size of the 
plasmids with a pET 58210 marker, the following colonies appeared 
to be the mutated clones. 
Colony number 
E160D mutation 1，2，4，5，6，7，8，9，10, 12 
E160A mutation 5，6，7，8 
SEAAR mutation 1，2, 3，4 
Restriction digestion of plasmid from transformants 
In order to facilitate restriction digestion and subsequent DNA 
sequencing, plasmids of colony number 8 of E160D mutation, number 
5 of El60A mutation and number 4 of ASEAAR mutation were 
isolated to higher purity by Qiagen cartridge (Section 2.1.4). The 
purified plasmids were digested with Nco I and BamH I and analysed 
by 1% agarose gel electrophoresis. As shown in Fig 3.3, digestion of 
the three plasmids and pET 58210 gave the same pattern of fragments: 
a 0.7 kb fragment of the TCS cDNA and a 4.6 kb fragment of the 
expression vector. Hence, the selected clones may be the mutated ones. 
Finally the mutations were confirmed by DNA sequencing. 
DNA sequencing 
DNA sequences concerning the mutated sites of TCS were shown in 
Fig. 3.4. It was shown that GAG codon of glutamate-160 was mutated 
to GAC (encoding aspartate) in E160D mutant and GCT (encoding 
alanine) in E160A mutant. The DNA sequence "TCT GAG GCT GCG 
AGG" encoding serine-156, glutamate-160, alanine-161, alanine-162 
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Fig. 3.3 Restriction digestion of plasmids from transformed colonies. 
Colony no.8 of E160D (uncut plasmid，lane A5), colony no.5 of E160A (uncut plasmid， 
lane B7), colony no.4 of ASEAAR mutation (uncut plasmid, lane B6) and pET58210 
(uncut plasmid, lane A4，B5) were digested with Nco I and 5amH I (cut plasmid，lane 
Al ’ B l , B2, B3) and analyse by 1% agarose gel electrophoresis. 
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Fig. 3.4 Confirmation of mutation by DNA sequencing. 
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and argiiiine-163 was deleted from TCS cDNA. The mutated plasmids 
were named pET E160D，pET E160A and pET SEAAR respectively. 
3.2,2. Construction of E189A and E160AE189A 
mutants 
Construction of pACYC 58210 
The strategy of construction is shown in Fig. 2.3. pET 58210 and 
pACYC 177 were digested with Pst I and BamH I. 0.4 kb fragment of 
pET 58210 was ligated to 3.0 kb fragment of pACYC 177 to form 
pACYC 58210. The plasmid from the transformed colonies was 
digested with Pst I and BamH I to confirm whether the recombinant 
plasmid carried the appropriate insert (Fig. 3.5, lane 2). 
Construction of pACYC E189A 
The strategy of construction is shown in Fig. 2.4 and the methods are 
• described in Section 2.2.2. PCR was carried out as described in Section 
2.19. All of the PCR product was loaded to a 1% agarose gel. After 
electrophoresis, DNA fragments of 0.26 kb were obtained as expected 
(Fig 3.6, lane 1). The 0.26 kb fragments were purified by GeneClean® 
kit (Section 2.1.8). After digestion with Pst I and Sea /，the 0.26 kb 
fragments were ligated to 3.1 kb fragment of pACYC 58210 (Fig 3.6， 
lane 4). Control ligation reactions with the linearized vector alone were 
also set up. The ligated DNA was transformed into Escherichia coli 
strain DH5a. Fourteen transformed colonies were obtained. 
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Fig. 3.5 Restriction digestion of pACYC58210. pACYC58210 (lane 
2) and pACYC177 (lane 3) were digested with Pst I and BamH L It was 
noted that a 0.3kb insert of TCS was cut out in lane 2. Lane 1 was the X 
Hind n i marker. 
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Fig. 3.6 PCR product of El89A mutation 
Lane 1: PCR product of E189A mutation 
Lane 2:1 Hind i n digested marker 
Lane 3: 123bp ladder marker 
Lane 4: pACYC58210 digested with Sea I and Pst I 
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Screening of mutant 
Plasmid from transformed colonies were screened firstly by their size. 
11 of the 12 colonies picked appeared to have the same size as the 
wild-type pACYC 58210. 
The oligo E189A would also create a unique Hae II site in TCS cDNA. 
It was known that wild-type pACYC 58210 has two Hae 11. If the 
plasmid contains a E189A mutation, the mutated plasmid should 
contain three Hae II sites. Therefore, plasmids of colony number 1，3， 
5，7 and 9 were digested with Hae II and analysed by 1% agarose gel 
electrophoresis. It was shown in Fig. 3.7 that plasmids from all of the 
5 colonies contains three Hae II sites. 
Plasmids from 4 colonies were sequenced. Fig. 3.8 shows the results 
of DNA sequencing of plasmids from colony number 3 and 4. It was 
found that the GAA codon of glutamate-189 was mutated to GCC 
(encoding alanine) and the sequence "TCTGCT" was mutated to 
"AGCGCT" which create a Hae II site without affecting the coding 
sequence of the TCS gene. However, a DNA sequence of 
"ACTAATA" or "ACTAATAA" was inserted between "AGT" and 
"ACT" of 5ca / site (Fig 3.8). 
In order to remove the insertion, plasmids from colony number 3 and 
pACYC 58210 were digested with Sea I and Pst I. The 0.26 kb 
fragment containing the E189A mutation was ligated to the 3.0 kb 
fragment from pACYC 58210. Plasmids from transformed colonies 
were also screened by their size and restriction digestion with Hae II 
and the mutation was finally confirmed by DNA sequencing. It was 
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Fig 3.7 Screening of E189A mutants 
Plasmids from colony no.l, 3，5，7 and 9 of E189A mutant (lane 2, 3，4， 
5，6) and pACYC58210 (lane 7) were digested with Hae H. Lanes 1 and 
8 were 1 Hind HI marker. 
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Fig. 3.8 Confirmation of mutation by DNA sequencing. 
It was noted that GAA codon of glutamate-189 was mutated to GCC and the sequence 
"TCTGCr' was mutated to “AGCGCT which creae a Hae H site. However, a DNA 
sequence of "ACTAATAA" or “ACTAATA，，was inserted between “AGTT and “ A C T 
of a Sea I site. 
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Fig. 3.9 Confirmation of mutation by DNA sequencing. 
It was noted the inserted DNA sequence was removed and the plasmid 
sequenced was named pACYC E189A. 
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found that GAG codon of glutamate-189 was mutated to GCC and a 
Hae II site was created in plasmid from colony number 4 without any 
second site mutation. (Fig. 3.9) The plasmid was named pACYC 
E189A. 
Construction of pACYC E160AE189A 
The strategy of construction is shown in Fig 2.4. PGR was carried out 
as described in Section 2.2.2. All of the PGR product was loaded on a 
1% agarose gel. After electrophoresis, DNA fragments of 0.26 kb 
were obtained as expected (Fig 3.10，lane 1). The 0.26 kb fragments 
were purified by GeneClean® kit (Section 2.1.8). After digestion with 
Pst I and Sea I, the 0.26 kb fragments were ligated to 3.1 kb fragment 
of pACYC 58210 (Fig 3.6, lane 2). Transformation of ligated DNA 
gave 104 colonies. 
Screening of mutant 
Plasmid from transformed colonies were screened firstly by their size. 
9 of the 10 colonies picked appeared to have the same size as the wild-
type pACYC 58210. 
As explained before, if the plasmid contains a E189A mutation, the 
mutated plasmid should contain three Hae II sites. Therefore, plasmids 
of colony number 2, 4, 6 and 11 were digested with Hae II and 
analysed by 1% agarose gel electrophoresis. It was shown in Fig. 3.11 
that plasmids from all of the 4 colonies contains three Hae II sites. 
Plasmids from 2 of 10 colonies were sequenced. It was found that the 
GAA codon of glutamate-189 was mutated to GCC (encoding alanine) 
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Fig. 3.10 PCR product of E160AE189A mutation 
Lane 1: 0.26kb PCR fragment of E160AE189A mutation 
Lane 2: 123bp ladder marker. 
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Fig. 3.11 Screening of E160AE189A mutant. 
Plasmids from colony number 2, 4，6，11 (lane 1, 2, 3，4) were digested 
with Hae H Lane 5 was 123 bp ladder marker. 
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and the sequence "TCTGCT" was mutated to "AGCGCT" which create 
a Hae II site without affecting the coding sequence of the TCS gene. 
The mutated plasmid was named pACYC E160AE189A. 
Construction of pET E189A and pET E160AE189A 
Mutated TCS cDNA in pACYC vector was subcloned back to pET 
expression vector. (Fig. 2.4). pACYC E l 8 9 A and pACYC 
E160AE189A was digested with Sal I and BamH L After digestion, the 
0.28 kb fragment was ligated to 4.6 kb fragment of pET 58210 cut 
open by Nco I and BamlA I and 0.47 kb fragment of pTrc 58210 (Fig 
3.1c, lane 1 and 2). Control ligation reactions without the addition of 
0.28 kb PCR fragments were also set up. The ligated DNA was 
transformed into Escherichia coli strain DH5a . The results of 
transformation are summarized as follows: 
E189A mutation E160AE189A mutation 
No. of colonies: 2 more than 200 
Control ligation 0 ND 
ND = not done 
Plasmids from transformed colonies were screened firstly by their 
size. 2 colonies of E189A mutant and 12 colonies of E160AE189A 
mutant was screened. It was found that plasmid from all colonies of 
E l 89A mutant and 9 colonies of E160AE189A mutant appeared to 
have same size as the wild-type pET 58210. 
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Plasmid from the transformed colonies were screened by restriction 
digestion with Hae IL Since a Hae II site was created in TCS cDNA， 
the digestion pattern of mutated and wild-type plasmid is different: 
The difference of restriction pattern 
Digested with Hae II: 
Wild-type pET 58210 E189A mutated 
(11 sites) (12 sites) 
1.876 kb 1.876 kb 
1.167 kb 0.722 kb and 0.445kb 
0.626 k b 0.626 k b 
0.439 kb 0.439 kb 
0.430 kb 0.430 kb 
0.370 kb 0.370 kb 
0.227 kb 0.227 kb 
0.083 kb 0.083 kb 
0.064 kb 0.064 kb 
0.054 kb 0.054 kb 
0.021 kb 0.021 kb 
It was shown in Fig. 3.12 that plasmid from colony number 1 and 2 of 
E l 89A mutation and number 1，11 and 12 of E160AE189A mutation 
appeared to be the mutated clones since the 1.167 kb fragment was not 
present in the restriction pattern. 
Plasmids from colony number 1 and 2 of E189A mutation and colony 
number 6 of El60AEl89A mutation were sequenced. Fig. 3.13 shows 
the results of colony number 1 of E189A mutation and colony number 
6 of E160AE189A mutation. It was found that the GAA codon of 
glutamate-189 was mutated to GCC (encoding alanine) and the 
sequence "TCTGCT" was mutated to "AGCGCT" which create a 
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Fig. 3.12 Hae II digestion of pET E189A and pET E160AE189A 
Plasmids from colony number 1，2 (lane A3, A4) of E189A mutation, colony number 
1，6，11,12 from E160AE189A mutation (lane B2, B3, B6，B7) and pET58210 (lane 
A2) were digested with Hae H. Lanes Al and B4 were 123bp ladder marker. Lanes A5 
and B5 were 1 Hind HI digested marker. 
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Fig. 3.13 Confirmation of mutated sequence. Plasmids from E189A 
and E160AE189A mutation were sequenced. It was found the GAA 
codon of glutamate-189 was mutated to GCC which encodes an alanine. 
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Hae II site without affecting the coding sequence of the TCS gene. The 
plasmids were named pET El89A and pET E160AE189A. 
3.2.3- Construction of E189D and E160AE189D 
mutants 
PGR and subcloning 
The strategy of construction is shown in Fig 2. and the methods are 
described in Section 2.2.3. PGR were carried out as described in 
Section 2.1.9. All of the PCR product were analyzed by 1% agarose 
gel electrophoresis. As shown in Fig. 3.14 (lane 1 and 4)，DNA 
fragment of 0.58 kb was obtained as expected. The 0.58 kb fragment 
was purified by GeneClean® kit (Section 2.1.8). On the other hand, 
pET E160AE189A was digested with Nco I and BamH I. The 0.75 kb 
was purified by agarose gel electrophoresis and GeneClean® kit. After 
digestion with Nco I and Hae II, the 0.58 kb fragments were ligated to 
0.17 kb fragment of pET E160AE189A and 4.6 kb fragment of pET 
8c. Control ligation reactions with the linearized vector alone were 
also set up. The ligated DNA was transformed into Escherichia coli 
strain D H 5 a . The results of transformation were summarized as 
follows: 
E189D mutation E160AE189D 
mutation 
No. of colonies: 344 100 
Control ligation 138 18 
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Fig. 3.14 PCR product of E189D and E160AE189D mutation 
Lane 1: 0.58kb PCR fragment of E189D mutation 
Lane 2: X Hind HE digested marker 
Lane 3: 123bp ladder marker 
Lane 4: 0.58kb PCR fragment of E160AE189D mutation 
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Screening of mutant 
Plasmid from transformed colonies were screened firstly by their size. 
24 colonies of each mutation were screened. Plasmids from 8 colonies 
of E189D and 6 colonies of E160AE189D mutation appeared to have 
the same size as the wild-type pET 58210. 
Plasmid from the transformed colonies were screened by restriction 
digestion with Hae 11. As explained before, a Hae E site was created in 
TCS cDNA，the digestion pattern of mutated and wild-type plasmid is 
therefore different. 
It was shown in Fig. 3.15 that plasmid from colony number 1，8，14， 
18 and 24 of E189D mutation and number 2, 9 and 11 of 
E160AE189D mutation appeared to be the mutated clones since the 
1.167 kb fragment was absent. 
Mutation was confirmed by DNA sequencing. It was found that the 
GAA codon of glutamate-189 of both mutation was mutated to GAC 
(encoding aspartate). The plasmids were named pET E189D and pET 
E160AE189D 
3.2.4. Construction of Q156A mutant 
The strategy of construction is shown in Fig. 2.6 and the methods are 
described in Section 2.2.4. PCR was carried out as described in 
Section 2.1.9. The 0.47 kb fragments were purified by GeneClean® 
kit (Section 2.1.8) and was then digested with Nco I and Sal L pET 
58210 was digested with Sal I and BamH I and pET 8c was digested 
with Nco I and BamH I. 0.47 kb fragment of PCR product, 0.28 kb of 
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Fig. 3.15a Plasmid frome colony no.l，8，14，16，18, 23，24 of E189D 
mutation (lane 2, 3，4, 5，6，7，8) were digested with Hae II and analysed 
by 1% agarose gel electrophoresis. Lane 1 and 8 were 1 Hind EI 
digested marker. 
1 • • • • • • • 
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Fig. 3.15b Plasmids from colony no.2, 9，11 of E160AE189D 
mutation (lane 1，2，3) were digested with Hae n and analysed by 2% 
gel electrophoresis. Lane 3 was 123bp ladder marker. 
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Fig. 3.16 Confirmation of mutation by DNA sequencing. Plasmids 
from E189D mutation were sequenced. It was found that GAA codon of 
glutamate-189 was mutated to GAC. 
84 
E160AE189D 
T C A G 
‘ . I 
... .. _ _ 
Leu-188 TTG . / 
Asp-189 GAC , / 
‘ ^ ^ ， 
. . ” � . . . 







Fig. 3.17 Confirmation of mutation by DNA sequencing. Plasmids 
from E160AE189D mutation were sequenced. It was found that GAA 
codon of glutamate-189 was mutated to GAC. 
� 
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the pET58210 and 4.6 kb of pET 8c were purified by agarose gel 
electrophoresis and GeneClean® kit. The purified fragments were 
analyzed by agarose gel electrophoresis (Fig. 3.18). The three 
fragments were ligated together and transformed into Escherichia coli 
strain DH5a. 4 transformed colonies were obtained. 
Screening of mutant 
Plasmid from the transformed colonies were screened by restriction 
digestion with Nco I and BamH L As shown in Fig. 3.19，digestion of 
plasmids from colony number 2, 3 and 4 gave a 0.7 kb fragment of 
the TCS cDNA and a 4.6 kb fragment of the expression vector. Hence, 
the selected clones may be mutated ones. 
Mutation was finally confirmed by DNA sequencing (Fig. 3.20). It 
was found that the CAG codon of glutamine-156 was mutated to GCG 
(encoding alanine). The plasmids were named pET Q156A. 
3-2.5- Construction of Q156AE160A and Q156AE189A 
The strategy of construction is shown in Fig. 2.7 and 2.8. pET El60A 
and pET E189A were digested with Sal I and BamH 1. pET Q156A 
was digested with Nco I and Sal 1. After agarose gel electrophoresis, 
the 0.28 kb Sal l-BamH I fragments and the 0.47 kb Nco l-Sal I 
fragment of pET Q156A were purified by GeneClean® kit (Section 
2.1.8). 0.47 kb fragment of pET Q156A were ligated to 4.6 kb Nco I-
B a m H I fragment of pET 8c and 0.28 kb of pET E l 6 0 A (for 
Q156AE160A mutation) or pET E189A (for Q156AE189A mutation). 
The ligated DNA was transformed into Escherichia coli strain DH5a. 
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Fig. 3.18 Purified digested fragment for construction of Q156A mutant. 
Lane 1: X Hind IE digested marker 
Lane 2: 4.6kb fragment of Nco l-BamH I digested pET8c 
Lane 3: 0.47kb fragment of Nco l-Sal I digested PGR product 
Lane 4: 0.28kb fragment of Sal I-BamH I digested pET58210 
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Fig. 3.19 Screening of Q156A mutant. 
Plasmids from colony no.l，2, 3，4 were digested with Nco I and BamH I (lane 2, 3， 
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Fig. 3.20 Confirmation of Q156A mutation. It was shown that CAG 
codon of glutamine-156 was mutated to GCG. 
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Plasmids were isolated from transformed colonies and were named 
pET Q156AE160A and pET Q156AE189A respectively. 
3.3. Discussion 
An efficient method using PGR to mutate TCS cDNA has been used. 
Employment of PGR in site-directed mutagenesis has several 
advantages. Template for mutagenesis is double-stranded DNA. Since 
plasmids can be handled more easily, expression vector containing 
TCS cDNA (such as pTrc 58210 or pET 58210) can be used directly 
as template. This saves a lot of subcloning procedures as well as 
troubles in purification of single-stranded template. Moreover, PGR 
amplifies the mutated fragment of TCS cDNA which provides 
sufficient amount of DNA for subsequent subcloning procedures. 
Finally, since practically all the DNA in the PGR product are 
mutated, the chance of cloning a mutated TCS cDNA is very high. 
PGR does have one limitation: restriction sites must be available on 
the synthesized PCR fragments to facilitate subcloning of mutated 
DNA into a vector such as pET 8c or pACYC 177. Therefore, the 
overall scheme of subcloning must be planned carefully to design the 
mutagenic primers. It is most convenient if there is a restriction site 
near the mutation site. Fortunately, all mutation sites of the present 
study have a nearby restriction site. 
In the case of ASEAAR, E160D and El60A mutations, a Sal I site 
flanking the 5' end of the mutation site was included in the mutagenic 
primers. Since Sal I site is not a unique site on pET 58210, a three-
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fragment ligation scheme (Section 2.2.1) was designed to subclone 
the mutated DNA fragment. Since three-fragment ligation was less 
efficient than two-fragment ligation，a control ligation reaction was 
designed to assay the efficient of the three-fragment ligation. In the 
control ligation reaction, two, instead of three, of the fragments 
were added. By comparing the number of transformed colonies of 
the two ligation reactions, the efficient of the three-fragment ligation 
can be estimated. The results showed that number of colonies of the 
three-fragment ligation of E160D，E160A and ASEAAR mutation to 
the control ligation were 42:1, 4:1 and 19:1 respectively. (Section 
3.2.1) A higher odd means a higher chance of picking out the right 
clone. Nevertheless, in the construction the odd was as low as 1.1 : 1. 
Efforts, such as altering the ratio of the fragments added, were made 
to optimize the ligation condition until the an acceptable recombinant 
to control ratio was obtained. It was experienced that the DNA 
fragments should be prepared as freshly as possible. On storage, the 
sticky end of the fragment may be degraded by nucleases and hence 
promotes self ligation. 
In the design of oligo E189A for E189A and E160AE189A 
mutations, a Sea I site franking the 5' end of the mutation site was 
included on the mutagenic primers. Unfortunately, Sea I is not a 
unique site of pET 58210 and it is a blunt-end cutter. A three-
ligation scheme could have been designed like the case of E160D 
mutation. However, it was anticipated that the efficient of a three-
fragment ligation involving a blunt-end ligation was very low. An 
indirect subcloning scheme was designed to bypass the problem of a 
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three-fragment ligation. pACYC 58210 contains part of the TCS 
cDNA was constructed (Fig. 2.3). Since Sea I and Pst I are unique 
sites of pACYC 58210，the PCR fragments with these two sites were 
subcloned to pACYC 58210 first. However, by unknown reason，the 
S � Z restriction enzyme did not cut the PCR fragment of E189A 
mutation efficiently. Incompletely digestion resulted in cloning the 
blunt-end PCR to the Sea I site of pACYC 58210. As revealed by 
DNA sequencing, this caused an insertion of DNA sequence 
"ACTAATA’’ or "ACTAATAA". (Fig. 3.7) 
PCR fragment pACYC 58210 
GCGAGTACTAATAA GCGAGTACTAATAA 
CGCTCATGATTATT CGCTCATGATTATT 
Incomplete Sea I 
digestion of 






To remove the insertion, the plasmids with the insertion was digested 
again with Sea I and Pst 1. The 0.26 kb fragment was subcloned to 
pACYC 58210. The insertion was removed in the resulting pACYC 
E189A，as revealed by DNA sequencing. Then the mutated portion 
of TCS cDNA was subcloned back to pET vector by a three-
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fragment ligation involving three sticky end cutter: Nco I, Sal I and 
BamH L 
Screening can be simplified by creating a restriction site in the 
mutated PCR fragments. In the design of oligo E189A, a sequence of 
"AGCGCT" was included to create a unique Hae II site in TCS 
cDNA. (Fig 2.1). The sequence of "TCTGCT" was mutated to 
"AGCGCT". Such mutation will not alter the coding sequence since 
both ’TCT" and "AGC" code for serine. Since only the DNA with 
E189A mutation has the additional Hae II site, it can be easily 
screened by restriction digestion with Hae 11. 
Creation of the Hae II site served another purpose: to facilitate the 
subcloning of E189D and E160AE189D mutants. In the design of 
oligo E189D, the site of Hae II was included instead of the Sea I site. 
Since Hae II is a sticky end cutter, a three-fragment ligation scheme 
can be designed for the subcloning of the E189D and E160AE189D 
mutants. 
Construction of Q156A, Q156AE160A and Q156AE189A mutants 
was more straight forward. A three-fragment ligation scheme was 
designed for the sucloning of the Q156A mutants. After obtaining 
the pET Q156A, the Q156AE160A and Q156AE189A double 
mutants were constructed simply by subcloning of TCS cDNA 




Purification of mutated 
TCS proteins 
Chapter 4 Expression and Purification of mutated 
TCS proteins 
4.1. Introduction 
In order to study the biological activities of mutants, efforts were 
made to express and purify the mutated proteins. Mutated plasmids 
were transformed into expression host Escherichia coli BL21 (DE3， 
pLysS). Isopropylthio-p-galactoside (IPTG) was added to induce 
protein expression in Escherichia coli. The bacteria were lysed by 
sonication. Proteins in the cytoplasmic fraction were purified by CM-
Sepharose CL-6B cation exchange chromatography and Mono-S fast 
protein liquid chromatography (FPLC). The purified proteins were 
analysed by SDS-polyacrylamide gel electrophoresis and western 
blotting. A total nine mutated proteins were purified: E160D，El 60A, 




4 .2丄 Expression and purification of E160D and 
E160A mutants 
500 ml bacterial culture was grown for expression of E160D and 
E l60A mutants. After sonication, the bacterial lysate was loaded to a 
CM Sepharose CL-6B column (1.5 cm x 16 cm). The column was 
washed with buffer A (50 mM NaH2P04 (pH 6.5) until OD280 of the 
eluent dropped below 0.05. Proteins adsorbed were washed by buffer 
B (0.5 M NaCl in buffer A). Fractions (3 ml each) were collected 
after the application of buffer B. The elution profiles were shown in 
Fig 4.1. Fractions 4 to 19 of E160D mutant and fractions 4 to 18 of 
E l 6 0 A mutant were pooled together respectively, dialysed and 
concentrated to about 16 ml by ultrafiltration. The concentrated 
eluents were then applied to a Mono S HR5/5 FPLC column. The 
chromatographic conditions and the elution profiles were shown in 
Fig. 4.2 and 4.3. E160D and E160A mutated proteins were eluted at 
about 21.0 minutes. 
V 
95 
OD 280 Data from "E160D.CM.2/12y«2" 
2 -
/wV-
u "1 1 1 1 
0 10 20 
Fraction no. 
Fig. 4.1a Elution profile of E160D mutated protein, CM-Sepharose 
CL-6B column. 
Data from "E1S0A.CWI.2/12/92" 
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Fig. 4.1b Elution profiles of E160A mutated protein, CM-Sepharose 
CL-6B. 
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Fig. 4.2 Elution profile of E160D mutated protein, Mono S 
FPLC. 
Volume of sample injected 0.5 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 5 - 30 min. 0% to 100% B，linear gradient 
30-35 min. 100% B 
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Fig. 4.3 Elution profile of El60A mutated protein. Mono S 
FPLC. 
Volume of sample injected 1 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
buffer D 1.0 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 
5 - 25 min. 0% to 80% B, 0% D 
25 -35 min. 100% D 
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4.2_2. Expression and purification of E189D and 
E160AE189D mutants 
500 ml bacterial culture was grown for expression of E189D and 
E160AE189D mutants. After sonication, the bacterial lysate was 
loaded to a CM Sepharose CL-6B column (2.5 cm x 8 cm). The 
column was washed with buffer A (50 mM NaH2P04 (pH 6.5) until 
O D 2 8 0 of the eluent dropped below 0.05. Proteins adsorbed were 
washed by buffer B (0.5 M NaCl in buffer A). Fractions (90 drops per 
fraction) were collected after the application of buffer B. The elution 
profiles were shown in Fig 4.4. Fractions 4 to 11 of E189D mutant 
and fractions 6 to 21 of E l60A mutant were pooled together 
respectively, dialysed and concentrated to about 16 ml by 
ultrafiltration. The concentrated eluents were then applied to a Mono S 
HR5/5 FPLC column. The chromatographic conditions and the elution 
profiles were shown in Fig. 4.5 and 4.6. E189D and E160AE189D 
mutated proteins were eluted at 21.0 to 21.4 minutes respectively. The 
improvement in purity was illustrated by SDS-PAGE. It was shown in 
Fig. 4.7 that mutated proteins were highly purified from crude 
bacterial lysates. 
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Fig. 4.4a Elution profiles of E189D mutated protein,CM Sephrose 
CL-6B column 
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Fig. 4.4b Elution profiles of E160AE189D mutated protein,CM 
Sephrose CL-6B column 
100 
E 1 8 9 D . D : V W D , W a v e l e n g t h = 2 8 0 nra 1200 -
1100- I jcj 1000- rrio … 









200- 1 \ 
100- S S 
^ ^ Ul 
八丨，I 丨 ， … 丨 … I 丨 • 刑 ， , - < ^ 丨 • • • 
rime ->0.'0() S.'OO 10： 00 15:00 20:00 25:00 30.00 35.00 
Fig. 4.5 Elution profile of E189D mutated protein, Mono S 
FPLC. 
Volume of sample injected 2 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 
5 - 30 min. 0% to 100% B，linear gradient 
30-35 min. 100% B 
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Fig. 4.6 Elution profile of E160AE189D mutated protein, Mono S 
FPLC. 
Volume of sample injected 2 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 5 - 30 min. 0% to 100% B, linear gradient 
30-35 min. 100% B 
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Fig. 4.7 Purification of TCS mutants as analyzed on 12.5% SDS-
PAGE. The gel was stained with commassie blue after electrophoresis. 
Lane 1: Low molecular weight marker (Pharmacia) 
Lane 2: Crude bacterial lysate of E189D mutant 
Lane 3: CM-Sepharose eluent of E189D mutant 
Lane 4: MonoS eluent of E189D mutant 
Lane 5: Crude bacterial lysate of E160AE189D mutant 
Lane 6: CM-Sepharose eluent of E160AE189D mutant 
Lane 7: MonoS eluent of E160AE189D mutant 
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Expression and purification of E189A and 
E160AE189A mutants 
500 ml bacterial culture was grown for expression of E189A and 
E160AE189A mutants. After sonication, the bacterial lysate was 
loaded to a CM Sepharose CL-6B column (2.5 cm x 8 cm). The 
column was washed with buffer A (50 mM NaH2P04 (pH 6.5) until 
OD280 of the eluent dropped below 0.05. Proteins adsorbed were 
washed by buffer B (0.5 M NaCl in buffer A). Fractions (90 drops per 
fraction) were collected after the application of buffer B. The elution 
profiles were shown in Fig 4.8. Fractions 6 to 23 of E189A mutant 
and fractions 8 to 28 of E160AE189A mutant were pooled together 
respectively, dialysed and concentrated to about 16 ml by 
ultrafiltration. The concentrated eluents were then applied to a Mono S 
HR5/5 FPLC column. The chromatographic conditions and the elution 
profiles were shown in Fig. 4.9 and 4.10. E189A and E160AE189A 
mutated proteins were eluted at 21.0 and 23.7 minutes respectively. It 
was noted the elution time for E160AE189A mutants was longer than 
other mutants. The improvement in purity was illustrated by SDS-
PAGE. It was shown in Fig. 4.11 that mutated proteins were purified 
from crude bacterial lysates. 
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Fig. 4.8a Elution profiles of E189A mutated protein,CM Sephrose 
CL-6B column 
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Fig. 4.8b Elution profiles of E160AE189A mutated protein，CM 
Sephrose CL-6B column 
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Fig. 4.9 Elution profile of E189A mutated protein, Mono S FPLC. 
l ^ t s 一 e IoIm NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 m l / m l Gradient: 0 - 5 min. 0% B 5 - 30 min. 0% to 100% B, linear gradient 30-35 min. 100% B 
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Fig. 4.10 Elution profile of E160AE189A mutated protein, Mono S 
FPLC. 
Volume of sample injected 0.1 ml hmfivr A 10 mM NaH2P04 (pH6.5) 
b X r B 0.1 M NaCl in buffer A 
Flow rate: 1 m l / m l Gradient: 0 - 5 min. 0% B 5 . 30 min 0% B to 100% B, linear gradient 
30-35 min. 100% B 
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Fig. 4.11 Purification of TCS mutants as analyzed on 12.5% SDS-
PAGE. The gel was stained with commassie blue after electrophoresis. 
Lane 1: Low molecular weight marker (Pharmacia) 
Lane 2: Wild-type TCS 
Lane 3: Crude bacterial lysate of E189A mutant 
Lane 4: CM-Sepharose eluent of E189A mutant 
Lane 5: MonoS eluent of E189A mutant 
Lane 6: Crude bacterial lysate of E160AE189A mutant 
Lane 7: CM-Sepharose eluent of E160AE189A mutant 
Lane 8: MonoS eluent of E160AE189A mutant 
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4-2-4. Expression and purification of Q156A and 
Q 1 5 6 A E 1 6 0 A m u t a n t s 
500 ml bacterial culture was grown for expression of E189A and 
E160AE189A mutants. After sonication，the bacterial lysate was 
loaded to a CM Sepharose CL-6B column (1.5 cm x 16 cm). The 
column was washed with buffer A (50 mM NaH2P04 (pH 6.5) until 
O D 2 8 0 of the eluent dropped below 0.05. Proteins adsorbed were 
washed by buffer B (0.5 M NaCl in buffer A). Fractions (90 drops per 
fraction) were collected after the application of buffer B. The elution 
profiles were shown in Fig 4.12. Fractions 12 to 20 of Q156A mutant 
and fractions 9 to 14 of E160AE189A mutant were pooled together 
respectively, dialysed and concentrated to about 16 ml by 
ultrafiltration. The concentrated eluents were then applied to a Mono S 
HR5/5 FPLC column. The chromatographic conditions and the elution 
profiles were shown in Fig. 4.13 and 4.14. Q156A and Q156AE160A 
mutated proteins were eluted at 20.7 and 20.0 minutes respectively. 
The improvement in purity was illustrated by SDS-PAGE. It was 
shown in Fig. 4.15 that mutated proteins were purified from crude 
bacterial lysates. 
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Fig. 4.12a Elution profiles of Q156A mutated protein,CM Sephrose 
CL-6B column 
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Fig. 4.12b Elution profiles of Q156AE160A mutated protein,CM 
Sephrose CL-6B column 
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書M« I争* 1 Fig. 4.13 Elution profile of Q156A mutated protein, Mono S FPLC. 
Volume of sample injected 1 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 八 ” ” 
5 - 30 min. 0% B to 100% B，linear gradient 
30-35 min. 100% B 
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Fig. 4.14 Elution profile of Q156AE160A mutated protein, Mono S 
FPLC. 
Volume of sample injected 1 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 0.1 M NaCl in buffer A 
Flow rate: 1 ml / ml 
Gradient: 0 - 5 min. 0% B 5 - 30 min 0% B to 100% B，linear gradient 
30-35 min. 100% B 
112 
.. � 
I I . 
I J ^ 一 — 」 2 M 3 4 5 6 
••丨* 一……--一 一 ..-•"xasgasgTiiiiiiii Ii I  I 画 —_丨丨丨丨丨|丨丨_.__丨丨丨.. 热 . ~ - ~ 
！ -
jam 1 
— ^ ^ — ^ M 藝 _ 
. � … _ m _ 
曙 _ 
j F i g � 4 � 1 5 Purification of TCS mutants as analyzed on 12.5% 
SDS-PAGE. The gel was stained with commassie blue after 
electrophoresis. 
LaneM: Wild-type TCS 
Lane 1: CM-Sephai'ose eluent of Q156AE160A mutant 
Lane 2: MonoS eluent of Q156AE160A mutant 
Lane 3: Crude bacterial lysate of Q156A mutant 
Lane 4: Flow through of CM-Sepharose 
Lane 5: CM-Sepharose eluent of Q156A mutant 
Lane 6: Mono S eluent of Q156A mutant 
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4.2.5- Expression and purification of Q156AE189A 
mutant 
Two litres bacterial culture was grown for expression of E189A and 
E160AE189A mutants. After sonication, the bacterial lysate was 
loaded to a CM Sepharose CL-6B column (1.5 cm x 16 cm). The 
column was washed with buffer A (50 mM NaH2P04 (pH 6.5) until 
OD280 of the eluent dropped below 0.05. Proteins adsorbed were 
washed by buffer B (0.5 M NaCl in buffer A). Fractions (90 drops per 
fraction) were collected after the application of buffer B. The elution 
profiles were shown in Fig 4.16. Fractions 23 to 30 of Q156AE189A 
mutant were pooled together respectively, dialysed and concentrated to 
about 16 ml by ultrafiltration. The concentrated eluents were then 
applied to a Mono S HR5/5 FPLC column. The chromatographic 
conditions and the elution profiles were shown in Fig. 4.17. 
Q156AE189A mutated proteins were eluted at 12.8 minutes. 
4.2.6. Analysis of protein purity by SDS-PAGE and 
Western blotting 
The purity of the mutated proteins were analysed by SDS-PAGE and 
Western blotting. All nine purified proteins and natural TCS were 
analysed by 12.5% polyacrylamide gel. It was shown in Fig. 4.18A 
that the proteins were purified to at least 95% homogeneity. 
Immunological activity of the proteins were also analysed by western 
blotting. Rabbit anti-TCS serum and anti-rabbit IgG antibodies 
conjugated with alkaline phosphatase were used to detect the proteins 
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Fig. 4.16 Elution profiles of Q156AE189A mutated protein,CM 
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Fig. 4.17 Elution profile of Q156AE189A mutated protein, Mono 
SFPLC. 
Volume of sample injected 2 ml 
buffer A 10 mM NaH2P04 (pH6.5) 
buffer B 1.0 M NaCl in buffer A 
Flow rate: 1 ml /ml Gradient: 0 - 5 min. 0% B ^ 5 - 30 min 0% B to 100% B, linear gradient 
30-35 min. 100% B 
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Fig. 4.18 Analysis of protein purity by (A) SDS-PAGE and (B) 
Western blot. 
Lane 1: Q156AE189A Lane 6: E189A 
Lane 2: Q156AE160A Lane 7: E189D 
Lane 3: Q156A Lane 8: E160A 
Lane 4: E160AE189A Lane 9: E160D 
Lane 5: E160AE189D Lane 10: natural TCS 
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4.3. Discussion 
Nine mutated proteins were successfully expressed in Escherichia coli 
and purified to homogeneity. pET vector system was employed to 
express TCS cDNA in E. coli (Studier et aL, 1988). This vector 
contains the T7 (|)10 promoter and (j) terminator (Fig. 4.19). TCS 
cDNA was cloned into the pET 8c at the Nco I and BamU I sites to 
form pET 58210. T7 (^10 promoter was not recognized by bacterial 
RNA polymerase but by bacteriophage T7 RNA polymerase. 
Therefore, the TCS cDNA is only expressed in specific expression 
host. The expression host BL21 (DE3，pLysS) employed is a lysogen 
harboring the bacteriophage T7 RNA polymerase gene under the 
control of the lacUV5 promoter. Upon induction by IPTG, T7 RNA 
polymerase was expressed which in turn directed the expression of 
TCS cDNA under the control of T7 (j) 10 promoter. Basal level 
expression of TCS cDNA was surpressed by the T7 lyzozyme, an 
inhibitor of T7 RNA polymerase, encoded in the plasmid pLysS 
residing in the BL21 (DE3, pLysS). 
The T7 lyzozyme also served to lyse the bacterial cells. It was 
observed that a simple freeze and thaw was enough to release the 
intracellular T7 lyzozyme and lyse the cells. However, sonication was 
done to ensure complete lysis of cells. 
Majority of the mutated proteins expressed formed inclusion bodies in 
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Fig. 4.19 pET 8c vector map. 
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the E. coli. However, a substantial amount of proteins was still present 
in the soluble cytoplasmic fraction. Since the yield of protein from the 
cytoplasmic fraction was satisfactory (10 to 20 mg of protein per liter 
of induced E. coli culture), attempt to solubilize the inclusion bodies 
was not performed. 
The mutated proteins in the cytoplasmic fraction were purified by a 
two-step purification scheme. Since TCS is very basic (pi = 9.4), it 
was expected that the mutated proteins, without major change in their 
basicity, would bind to cation exchanger. The CM-Sepharose CL-6B 
cation exchange chromatography served to remove a large amount of 
impurities from the crude bacterial lysates. It was shown in Fig 4.7 
(lanes 4，7) and 4.11 (lanes 3, 6) that the eluents of the CM-Sepharose 
CL-6B column were highly enriched in mutated TCS proteins. 
The mutated proteins were further purified by Mono S cation 
exchange fast protein liquid chromatography (FPLC). A gradient of 
either 0 - 0.1 M of NaCl (25 ml) or 0 - 1.0 M of NaCl (25 ml) was 
employed to elute the mutated TCS. The elution time of the mutated 
proteins were comparable to that of wild-type TCS: 20 to 23 minutes 
for 0 - 0.1 M NaCl gradient and 12 to 13 minutes for 0 to 1.0 M NaCl 
gradient. This implied that the mutations contribute little to the overall 
charge properties of the proteins. The results are reasonable since the 
mutations were focused on the active site residues which locate in the 
interior of the protein. On the other hand, modification of residues on 
the surface of the protein could have a larger effect on the overall 
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charge properties. Unpublished results (Chan，W. L.，personal 
communication) showed that mutation of arginine-29 to cysteine, 
which removed a positive charged amino acid on the surface of TCS, 
would result in a protein that binds poorly to CM-Sepharose CL-6B 
column. 
Purified proteins were determined to have the same size as the wild-
type TCS by SDS-PAGE (Fig. 4.18). Moreover, the proteins also 
showed similar reactivity to anti-TCS serum in Western blotting. 
According to the elution properties of Mono S cation exchange 
column, the size and the immunological reactivities, the purified 
proteins were confirmed to be the mutated TCS. 
In addition to the nine mutants, efforts were made to express and 
purify the ASEAAR mutant. ASEAAR mutant was expressed to high 
level in E. coli. However, as determined by Western blotting all the 
expressed protein formed inclusion bodies. (Fig. 4.20a) Attempts were 
made to purify the protein in the inclusion bodies. Inclusion bodies 
were dissolved in 6M guanidine hydrochloride. However, after 
refolding, the mutated protein remained insoluble and was only found 
in the precipitate (Fig. 4.20b, lane 5). The deletion of S159EAAR 
seems to disrupt the proper folding and renders the protein insoluble. 
Site-directed mutagenesis of ricin, a protein homologous to TCS, at 
these sites also produced an insoluble proteins. Frankel et al. (1990) 
showed that ricin with mutation of arginine-180, which correspond to 
arginine-163 of TCS, to methionine, alanine and glutamine were 
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Fig. 4.20a. Western blot. Lane M: natural TCS. Lane 1: pellet fraction. Lane 2: supernatant fraction. 
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Fig. 4.20b Solubilization of inclusion bodies of ASEAAR mutant 
Induced culture was harvested and then lysed by sonication. After centrifuation at 
21000 g，the pellet (lane 2) and the supernatant (lane 1) was analysed by SDS-PAGE. 
Inclusion bodies in the pellet was dissolved in 6M guanidine HCl. Refolding of the 
protein was initiated by lowering the concentration of guanidine HCl to 0.1 M by rapid 
dilution to 1800 ml of lOmM phosphate buffer at pH6.5. The protein solution was 
concentrated to 200 ml by ultrafiltration and was analysed by SDS-PAGE (lane 3). The 
protein solution was centrifuged to spin down the precipitates. While mutated TCS was 
found in the pellet fraction (lane 5), it was not detectable in the soluble fraction (lane 4). 
Lane 7 was the low molecular weight marker (Pharmacia). 
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insoluble. This indicated that the concerned amino acid was important 
in dictating the folding of the protein. The segment of S159EAAR 
belongs to alpha helix E of the TCS and forms many inter-chain 
hydrogen bonds which hold the helix in correct position. Moreover, a 
deletion of five amino acid SEAAR may alter the folding in such a 
way that exposes hydrophobic amino acids to the exterior of the 
protein. Inter-molecular interaction of the hydrophobic region would 
result in the formation of insoluble aggregate. 
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Chapter 5 
Biological Assay of 
mutated proteins 
Chapter 5 Biological Assay of mutated proteins 
5.1. Introduction 
The biological activities of the mutated proteins were assayed by cell-
free translation system using rabbit reticulocyte lysate as a source of 
ribosome, mRNA and other endogenous factors for translation. The 
raw data were fitted to a logistic curve and the ID50, the concentration 
of protein to achieve 50% inhibition, of the mutated proteins were 
found. The abilities of the mutants to inhibit protein synthesis were 
compared by their ID50. The abilities of one of the mutants 
E160AE189A to cleave the N-glycosidic bond of rRNA was also 
studied. From the biological activities of the mutated proteins, the 
role of glutamate-160, glutamate-189 and glutainine-156 were 
proposed. Finally, a putative mechanism for N-glycosidase activity of 
TCS was presented. 
5.2. Results 
5.2.1- Ribosome inactivating activity assay 
Ribosome inactivating activities of the mutated proteins were assayed 
by cell-free translation. 100% translation was defined by the 
radioactive count of the control, assuming that bovine serum albumin 
does not inhibit protein synthesis. The raw data of % translation were 
averaged and fitted to the following equation, which represents a 
logistic curve - a common curve type for dose-response curve: 
a where a = asymptotic maximum y = b = slope parameter b(x-c) c = value of x at inflection point 1+e d 二 asymptotic minimum 
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Fig. 5.1 Inhibition of protein synthesis by natural and mutated TCS. 
The protein synthesis was quantified by the amount of radioactive 
methionine incorporated into TCA precipitated substances. Radioactivity 
countings were done in triplicates. The assay was performed 4 times for 
natural TCS and El60A mutant and 2 times for E160D mutant. Error 
bars represent the standard deviations of the data. 
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Fig 5 2 Inhibition of protein synthesis by mutated TCS. 
The protein synthesis was quantified by the amount of radioactive 
methionine incorporated into TCA precipitated substances. Radioactivity 
countings were done in triplicates. The assay was performed 4 times for 
the E160AE189A and E160AE189D mutant and 2 times for E189A and 
E189D mutant. Error bars represent the standard deviations of the data. 
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Pig 5 3 Inhibition of protein synthesis by natural and mutated TCS. 
The protein synthesis was quantified by the amount of radioactive 
methionine incorporated into TCA precipitated substances. Radioactivity 
countings were done in triplicates. The assay was performed 4 times for 
natural TCS and 2 times for other mutants. Error bars represent the 
standard deviations of the data. 
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The curve fitting was calculated by a software, Sigma Plot v. 4.1 
(Jandel Scientific), running at a Macintosh computer. Both the raw 
data and the fitted data were plotted (Fig. 5.1-5.3). The dots in the 
graphs are averaged % translation and the error bars represent the 
standard deviation of the data. The smooth curves in the graphs 
represent the curve-fitted data. ID50s were determined and 
summarized in Fig. 5.4. 
For the sake of making the graphs more presentable, the results of the 
mutants were plotted in separate graphs. Related results were plotted 
in the same graph. Fig. 5.1 concerns the effect of mutation at 
glutamate-160. Mutation of glutamate-160 to aspartate and alanine 
resulted in loss of activities by about 50 and 15 folds respectively. It 
was noted that the activity of the alanine mutant was higher than that 
of the aspartate mutant. 
Fig. 5.2 illustrates the effect of double mutation at glutamate-160 and 
189. The results showed that the first mutation at glutamate 189 had 
little effect to the activities. The single mutants, E189D and E189A, 
were 1.6 and 1.1 folds respectively less active than wild-type TCS. On 
the contrary, a second mutation of glutamate-160 to alanine caused a 
drastic drop, by about 700 and 1800 folds, of activities. 
Fig. 5.3 shows the results of mutation concerning glutamine-156. The 
activities of Q156A and Q156AE189A were of the same order of 
magnitude of wild-type activities, with a decrease of activities by 1.6 
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ID50 nM relative to nTCS decrease in activity 
nM % no. of folds 
nTCS 0.0253 
E160D 1.3298 1.90% 52.6 
E160A 0.3675 6.88% 14.5 
E189D 0.0401 63.09% 1.6 
E189A 0.0281 90.04% 1.1 
E160AE189D 17.9152 0.14% 708 
E160AE189A 45.0916 0.06% 1782 
Q156A 0.0397 63.73% 1.6 
Q156AE160A 1.7189 1.47% 67.9 
Q156AE189A 0.0697 36.30% 2.8 
Fig. 5.4 Biological activities of wild-type and mutated TCS 
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and 2.8 folds respectively. The Q156AE160A was much less active, 
which decrease in activities by about 70 folds. 
5-2.2. N-glycosidase activities of E160AE189A mutant 
The ability of the E160AE189A mutant to depurinate 28S rRNA was 
tested as described in the method and material section. Depurinated 
rRNA is susceptible to attack of primary amine such as aniline and the 
rRNA is cleaved at the depurinated site. Zhang and Liu showed that a 
fragment of about 450 nucleotides, named R-fragment by Endo Y. 
(Endo and Tsurugi, 1988)，was cleaved from TCS treated 28S rRNA 
by aniline. It was also determined that the protein cleaves specifically 
the N-glycosidic bond at adeiiine-4324 of 28S rRNA (Zhang and Liu, 
1992) and hence renders the RNA susceptible to aniline cleavage. 
Based on the above background information, a experiment was 
designed to study the N-glycosidase activities of E160AE189A mutant. 
Fig. 5.5 shows the results of the experiment. The results showed that 
the E160AE189A mutated protein was able to produce a fragment 
(lane 4) of the same size as the R-fragment, as indicated by an arrow, 
produced by wild-type TCS (lane 2). Lane 3 and 5 showed that R-
fragment was produced only if the 28S rRNA was treated by aniline, 
suggesting the release of R-fragment was not due to the nuclease 










Fig. 5.5 N-glycosidase activity of E160AE189A mutant. 
Lane 1: RNA from BSA treated rabbit reticulocyte lysate, cleaved by aniline. 
Lane 2: RNA from BSA treated rabbit reticulocyte lysate. 
Lane 3: RNA from E160AE189A mutant treated rabbit reticulocyte lysate，cleaved by aniline. 
Lane 4: RNA from E160AE189A mutant treated rabbit reticulocyte lysate. 
Lane 5: RNA from TCS treated rabbit reticulocyte lysate, cleaved by aniline. 
Lane 6: RNA from TCS treated rabbit reticulocyte lysate. 
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5.3. Discussion 
5-3.1- Role of glutamate-160 
From three-dimensional structure and sequence homology of TCS 
with other RIPs (Fig. 1.4), glutamate-160 was surmised to be 
important in the catalysis of TCS. In order to study the role of 
glutamate-160, the amino acid was mutated to aspartate. The 
ribosome-inactivating activity of the E160D mutant was decreased by 
about 50 folds (Fig. 5.4). The mutation was conservative in the sense 
that the side arm of glutamate-160 was shortened only by one -CH2-
group. It was impressed that such a small modification would result in 
significant decrease in activity. This suggested that glutamate-160 
plays a significant role in the activity of the protein. Since shortening 
of the side arm resulted in large drop of activity, it was reasonable to 
postulate that the position of the carboxylate group of the glutamate-
160 is crucial to activity and presumably the functional group is 
essential for the catalysis of the TCS. 
It was learnt from the mutagenesis of ricin A-chain that mutation of 
glutamate-177, which corresponds to glutamate-160 in TCS, to alanine 
resulted in a mutant with higher activity than the aspartate-177 mutant 
(Schlossman et al” 1989). The results obscured the role of the 
carboxylate group for catalysis since the activity of the E177A mutant 
which do not have the functional group was higher than that of the 
E177D mutant having it. It was later found that the role of glutamate-
177 in E177A mutant could be fulfilled by another glutamate residue 
at 208 position (Frankel et al., 1990). 
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In the present study, glutamate-160 was also mutated to alanine. It was 
found that E160A mutant, which decreased in activity by 15 folds 
(Fig. 5.4)，was more active than the E160D mutant. The resemblance 
of the results from mutagenesis of TCS and ricin A-chain prompted us 
to search for the residue which can replace the role of glutamate-160 
in E l60A mutant. From sequence alignment of TCS with other RIPs 
(Fig. 1.4), it was found that glutamate-189 of TCS aligns with 
glutamate-208 of ricin A-chain. According to the three-dimensional 
model of TCS (Collin et al., 1990)，glutamine-189 was found to locate 
in the active site cleft. With the help of computer modeling, it was 
observed that by rotating the C-C bond of the side chain, the 
carboxylate group of glutamate-189 can be moved to the vicinity of 
glutamate-160. This suggested the feasibility of the postulation that 
glutamate-189 may replace the role of glutamate-160. Systematic 
modification at glutamate-189, creating single and double mutants, was 
performed to clarify the role the amino acid residue. 
A total number of four mutants were constructed to elucidate the role 
of glutamate-189 and -160; they were E189D, E189A，E160AE189D ‘ 
and E160AE189A. The results were summarized in Fig. 5.2 and 5.4. 
The effects of the single mutation at glutamate-189 were minor as 
shown by the small drop in activities of E189D and El89A. The 
E189A mutant retained about 90% activity of wild-type TCS. This 
suggested that glutamate-189 contributes no vital role to the activity of 
the wild-type TCS. On the contrary, the role of glutamate-189 in the 
E l 6 0 A mutant was shown to be much more significant by double 
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mutation analysis. The activities of the double mutants, E160AE189D 
and E160AE189A, were drastically decreased by about 700 and 1800 
folds (Fig. 5.4). When the activities of the double mutants were 
compared to that of E160A mutant, a second mutation of E189D and 
E l 89A caused a further decrease in activities by about 50 and 120 
folds. The results suggested that glutamate-189 plays an essential role 
in the activities of the El 60A mutant. This agreed with the postulation 
that glutamate-189 can substitute the role of glutamate-160 in El60A 
mutant. 
Computer-aided molecular modeling was performed to rationalize the 
role of glutamate-189. The computer software Quanta (Polygene, Inc.) 
was run on a Silicon Graphic Workstation. Based on the three-
dimensional structure of wild-type TCS, the glutamate-160 was 
changed to alanine and the side chain of glutamate-189 was rotated so 
that the carboxylate group was near the 160 position. Then the 
mutated structure was fine-tuned by energy minimization. The 
modeled structure of E160A mutant were superimposed on the 
structure of wild-type TCS (Fig. 5.6). It was shown that the 
carboxylate group of glutamate-189 of El60A mutant can be moved 
near the space where the carboxylate group of glutamate-160 once 
occupied and enjoyed a local minimum of energy there. The molecular 
model for El60A mutant presented agrees with the three-dimensional 
structure of El77A mutant of ricin A-chain. It was reported that the 
side chain of glutamate-208 is rotated to the vicinity of alanine-177 
and forms a hydrogen bond with arginine-180, which corresponds to 
arginine-163 of TCS (Kim et al., 1992). In our model for El60A 
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Fig. 5.6 Rotation of glutamate-189 in El60A mutant. Dotted line 
represents the structure of wild-type TCS and the solid line represents 
the model for El60A mutant. 
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mutant，the distance between NHl of arginine-163 and 0 E 2 of 
glutamate-189 is about 2.7 A, which is a reasonable distance for a 
hydrogen bond. Crystallographic analysis of the E160A mutant in the 
future will help us to confirm the role of glutamate-189. 
The importance of a carboxylate group in the catalytic process was 
illustrated by the fact that the activities of E160AE189A mutant, of 
which the carboxylate groups of both glutamate residues were 
removed, was about 1800 folds less active than the wild-type TCS 
(Fig. 5.4). 
5.3.2. A putative mechanism for N-glycosidase 
activity of TCS 
Since inhibition of protein synthesis by TCS is due to its RNA N-
glycosidase activity, glutamate-160 should play an important role in 
the catalysis. A catalytic mechanism could be helpful in explaining the 
role of glutamate-160. However, such mechanism for TCS is not 
available at the present time. 
It was known that acid hydrolysis is a typical mechanism for chemical 
cleavage of N-glycosidic bond. The reaction is initiated by protonation 
of the adenine ring which induce electron flow from the ribose ring 
oxygen to the adenine ring, forming an oxocarbonium ion 
intermediate. The reaction is then completed by attack of water to the 
unstable oxocarbonium ion. The rate-limiting step of the reaction is 
the formation of oxocarbonium ion. Stabilization of the oxocarbonium 
ion would enhance the rate of hydrolysis. An acid hydrolysis 
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mechanism has been proposed for catalysis of ricin A-chain 
(Monzingo and Robertas, 1992). 
According to acid hydrolysis mechanism, at least two features must be 
present in the active site to undergo the acid hydrolysis: a proton 
donor to activate bond cleavage and a negatively charged functional 
group to stabilize the oxocarbonium ion. Since the carboxylate group 
of glutamate-160 plays a vital role in the activity of TCS, it was 
surmised that glutamate-160 serves to stabilize the oxocarbonium ion 
intermediate. Moreover, kinetic studies of several mutants of TCS 
supported the postulated role of glutamate-160 (Shaw et al., 
unpublished data. Fig. 5.7). Comparing the results of Q156A and 
Q156AE160A mutants showed that a second mutation of E l60A 
affects mainly the kcat, decreased by about 8 folds and has little effects 
on the Km. This suggested that glutamate-160 is more essential for 
catalysis than for substrate binding. Kim et al (1992) also found that 
mutation of glutamate-177 of ricin A-chain, which corresponds to 
glutamate-160 of TCS, to alanine caused a 60-fold decrease in kcat 
without significant effect on Km. 
On the other hand, it was more difficult to locate the proton donor. 
Since the role of the proton donor is indispensable, it was assumed that 
the residue should be highly conserved. There are three invariant 
amino acid residues in the active site that could be the hydrogen 
donor: they are tyrosine-70, tyrosine-111 and arginine-163. Mutation 
of arginine-180 of ricin A-chain，which corresponds to arginine-163 
of TCS, to glutamine caused a large decrease in kcat without having 
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- nTCS E189A Q156A Q156AE160A Q156AE189A 
IDSO nM 0.0253 0.0281 0.0397 1.7189 0.0697 
relative to nTCS 100.00% 90.04% 63.73% 1.47% 36.30% 
Km (uM) 1.7 2.1 0.96 1.6 1.35 
relative to nTCS 1.000 1.235 0.565 0.941 0.794 
kcat (1/min) 926 658 235 30.6 230 
relative to nTCS 1.000 0.711 0.254 0.033 0.248 
kcat/Km (1/uM-min) 545 313 245 19 170 
relative to nTCS 1.000 0.575 0.449 0.035 0.313 
c 
Fig 5.7 Summary of kinetic data of wild-tpe and mutant TCS 
proteins. 
139 
significant effect on Km (Kim and Robertus, 1992). The results from 
ricin suggested that arginine-163 of TCS may be the proton donor. 
In order to device a mechanism for TCS, efforts were made to dock 
the substrate into the active site of TCS using computer-aided 
molecular modeling (Dong, unpublished data). TCS recognizes a loop 
structure at nucleotide 4139 to 4350 of 28S rRNA (Fig. 1.1). There 
are four highly conserved nucleotides GAGA on the loop and TCS 
cleaves the N-glycosidic bond of the first A. The tetxa nucleotides 
were regarded as the substrate in the modeling. According to the hints 
f rom the three-dimensional structure of substrate analogs in the active 
site of ricin (Monzingo and Robertus, 1992), we were able to dock the 
substrate GAGA to the active site of TCS (Fig. 5.8). 
According to the geometry of the active site-substrate complex, a 
mechanism for N-glycosidase activity of TCS was proposed (Fig. 5.9). 
Adenine ring of A-4324 of 28S rRNA is protonated by arginine-163 
and this attracts electron flow from the ribose oxygen to the ring, thus 
breaking the N-glycosidic bond. The oxocarbonium is stabilized by the 
carboxylate group of glutamate-160 and this contributes to the 
enhancement in the rate of reaction. Subsequent nucleophilic attack of 
water to C-1 of ribose complete the reaction and regenerates the 
enzyme. In the three-dimensional model of TCS, a water molecule 
(H20-333) , which may assume the role as a nucleophile, is held by 
arginine-163 in the vicinity of glutamate-160. 
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Fig. 5.9 A putative mechanism for N-glycosidase actiity of TCS 
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5-3.3- Role of glutamate-189 and glutamine-156 
The role of glutamate-189 is less significant in wild-type TCS. It was 
shown that mutation of E189A has no significant effect on the ID50 as 
well as kinetic properties (Fig. 5.7). However, it was observed that 
glutamate-189 is highly conserved among the RIPs from plant (Fig. 
1.4), suggesting the amino acid must play some role in natural TCS. 
One of the sensible guesses is that glutamate-189 may act as a back-up 
of carboxylate group, replacing the carboxylate group of glutamate-
160 in case it is lost and enhancing the survival of the protein. 
From the three-dimensional structure of TCS (Dong, unpublished 
data), it was found that the carboxylate group of glutamate-189 is 
paired with glutamine 156 via a hydrogen bond. Since glutamine-156 
is related to glutamate-189, mutagenesis at glutamine-156 was 
performed to understand the role of these two amino acid residues. 
Three mutants concerning the glutamine-156 were constructed: they 
were Q156A, Q156AE160A and Q156AE189A. Their biological 
activities were assayed and the results were shown in Fig. 5.3 and Fig. 
5.4. Since the glutamate-189 is hydrogen bonded to glutamine-156, 
the double mutant Q156AE160A was constructed to see whether 
removal of the glutamine-156 would help the rotation of glutamate-
189 to the vicinity of position 160. The results, however, showed that 
a second mutation of Q156A further reduce the activities of E l 60A 
mutant by about 4.7 folds. Other two mutants did not show large drop 
in activity. The reason why Q156A mutation had a larger effect on 
E160A mutant is not known. This may be due to impaired rotation of 
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glutamate-189. However, the results clearly indicated that glutamine-
156, like glutamate-189, does not directly participate in catalysis since 
the activity of Q156A was comparable to wild-type TCS. 
In order to have more understanding on the role of these residues, 
kinetic studies was done to determine the kcat and Km for the mutants 
(Shaw et al” unpublished data, Fig. 5.7). Mutation of E189A only 
have marginal effect to the value of Km and kcat, which decreased by 
1.2 and increased by 1.4 folds respectively. The kinetic data agreed 
with the ID50: both of them showed that glutamate-189 is not 
important in the catalysis of TCS. On the contrary, mutation of 
Q156A was shown to have a larger effect on the enzymatic kinetic of 
TCS. The kcat and Km were decreased by about 4 and 1.7 folds 
respectively. The ratio of kcat/Km, commonly regarded as a measure 
of the overall efficiency of an enzyme，was decreased only by about 
2.2 folds. The small drop in ID50 seems to be the resultant of two 
opposing effects of Q156A mutation: the decrease in kcat is 
compensated by improvement in substrate binding. 
Mutation of Q156A leaves an unpaired negative charged glutamate-
189 which may affect local structure of the protein. It was thought that 
removal of the glutamate-189 may reverse the effect of Q156A 
mutation. A double mutant of Q156AE189A was constructed to find 
the role of glutamate-189 in Q156A mutant. The results, however， 
showed that a second mutation of El 89A further increased the ID50 
and Km by 1.8 and 1.4 folds respectively, without significant change 
in kcat. Based on the evidence available, it is difficult to assign a role 
for glutamate-156. Glutamine-156 locates on the same helix, helix E 
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of TCS, with glutamate-160 and arginine-163. There is a slight 
bending at the end of helix E which renders the side chain of 
glutamate-160 and arginine-163 protruding to the solvent. It is 
possible that replacement of glutamine by alanine, a helix-builder, may 
alter the conformation of the helix and hence result in decreased kcat. 
However, the ultimate answer remains elusive until the three-
dimensional structure of Q156A mutant is elucidated. 
It was observed that there is always a corresponding glutamine residue 
in all RIPs containing a glutamate which corresponds to glutamate-189 
of TCS (Fig. 1.4). The two residues seems to be co-evolved. The 
results showed that the Q156A mutant, having the glutamate-189 but 
not glutamine-156, can retained only 64% of wild-type activity. If it is 
true that glutamate-189 serves as a back-up of carboxylate group for 
catalysis, the presence of glutamine-156 may be the result of fine-
tuning in evolution for maximizing the activity. 
5.3.4. Prospective and future studies 
One of the future direction of research is X-ray analysis of the 
mutated protein. An interesting candidate is the Q156A mutant. It is 
interesting to find that the Km for all three mutants involving 
glutamine-156 decrease. This suggested the binding of substrate to the 
mutated proteins is improved. The Km of Q156A mutant was 0.96 
uM, which improve the binding of substrate by about 1.7 folds. 
Solution of the three-dimensional structure of the mutant may help to 
explain why substrate binding is improved. Such experience can be 
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applied in the design of mutant TCS which have better substrate 
binding abilities. 
It was interesting to find that the E160AE189A mutant, despite both 
carboxylate groups were absent, can still inhibit protein synthesis in 
cell-free translation system. The ID50 for the mutant was 45 nM. As 
observed from the three-dimensional structure of TCS, there is no 
other negatively charge residues in the active site that can serve to 
stabilize the oxocarbonium ion. An experiment was designed to test 
whether the double mutant has N-glycosidase activity. The results 
suggested that the double mutant, despite in a much lower rate, was 
still able to cleave the N-glycosidic bond of A-4324 of 28S rRNA 
(Fig. 5.5). Apparently, there are other factors, in addition to 
stabilization of oxocarbonium ion by carboxylate group, that 
contribute to the lowering of energy barrier of the reaction. Similar 
experience came from mutagenesis of subtilisin f rom Bacillus 
amyloliquefaciens. Carter and Wells (1988) replaced the catalytic 
triad, serine-221, histidine-64 and aspartate-32 of subtilisin, with 
alanine. The triple alanine mutant was found to have a residual activity 
which is a thousand folds greater than non-enzymatic one. This was 
explained in terms of the stabilization of the transition state by the 
other amino acids outside the catalytic triad. Probably, some of the 
conserved amino acids in the active site of TCS such as arginine-163, 
tryptophan-192, tyrosine-70 and 111 has contributed to the transition 
state stabilization to certain extent. 
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5.4. Concluding remarks 
Protein engineering has been employed to probe the role of several 
active site residues of TCS. Evidence from the present study points to 
the involvement of a carboxylate group in the active site for catalysis. 
Glutamate-160 in wild-type TCS serves to provide the carboxylate 
group. On the other hand, glutamate-189 can serve as a back-up of the 
carboxylate group in case the functional group of glutamate-160 is 
lost. Although glutaimne-156 is highly conserved in plant RIPs, it does 
not participate directly in catalysis. It is interesting to find that 
mutation of Q156A would result in better substrate binding. Further 
study will be proceed to investigate the Q156A mutants. 
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Appendix 
A.1 Size of molecular weight markers 
A.1 .1 X Hind III digested DNA markers 
X DNA digested markers are made by digesting \ DNA with restriction 









A.1.2 Low molecular weight protein markers 
Low molecular weight protein markers were supplied from Pharmacia. 
The size of markers is as follows: 
Phosphorylase b 94,000 kDa 
Albumin 67,000 kDa 
Ovalbumin 43,000 kDa 
Carbonic anhydrase 30,000 kDa 
Trypsin inhibitor 20,100 kDa 
a-lactalbumin 14,400 kDa 
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